falseQ3000008894101/302022http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613MemberP1YP2YP3Y0.33330.33330.3333http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent00000889412021-02-012021-10-3100000889412021-11-26xbrli:shares00000889412021-08-022021-10-31iso4217:USD00000889412020-07-272020-10-2500000889412020-01-272020-10-25iso4217:USDxbrli:shares0000088941us-gaap:ForeignExchangeContractMember2021-08-022021-10-310000088941us-gaap:ForeignExchangeContractMember2020-07-272020-10-250000088941us-gaap:ForeignExchangeContractMember2021-02-012021-10-310000088941us-gaap:ForeignExchangeContractMember2020-01-272020-10-250000088941us-gaap:InterestRateSwapMember2021-08-022021-10-310000088941us-gaap:InterestRateSwapMember2020-07-272020-10-250000088941us-gaap:InterestRateSwapMember2021-02-012021-10-310000088941us-gaap:InterestRateSwapMember2020-01-272020-10-2500000889412021-10-3100000889412021-01-310000088941us-gaap:CommonStockMember2021-08-010000088941us-gaap:TreasuryStockMember2021-08-010000088941us-gaap:AdditionalPaidInCapitalMember2021-08-010000088941us-gaap:RetainedEarningsMember2021-08-010000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-08-010000088941us-gaap:ParentMember2021-08-010000088941us-gaap:NoncontrollingInterestMember2021-08-0100000889412021-08-010000088941us-gaap:RetainedEarningsMember2021-08-022021-10-310000088941us-gaap:ParentMember2021-08-022021-10-310000088941us-gaap:NoncontrollingInterestMember2021-08-022021-10-310000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-08-022021-10-310000088941us-gaap:AdditionalPaidInCapitalMember2021-08-022021-10-310000088941us-gaap:CommonStockMember2021-08-022021-10-310000088941us-gaap:TreasuryStockMember2021-08-022021-10-310000088941us-gaap:CommonStockMember2021-10-310000088941us-gaap:TreasuryStockMember2021-10-310000088941us-gaap:AdditionalPaidInCapitalMember2021-10-310000088941us-gaap:RetainedEarningsMember2021-10-310000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-310000088941us-gaap:ParentMember2021-10-310000088941us-gaap:NoncontrollingInterestMember2021-10-310000088941us-gaap:CommonStockMember2021-01-310000088941us-gaap:TreasuryStockMember2021-01-310000088941us-gaap:AdditionalPaidInCapitalMember2021-01-310000088941us-gaap:RetainedEarningsMember2021-01-310000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-310000088941us-gaap:ParentMember2021-01-310000088941us-gaap:NoncontrollingInterestMember2021-01-310000088941us-gaap:RetainedEarningsMember2021-02-012021-10-310000088941us-gaap:ParentMember2021-02-012021-10-310000088941us-gaap:NoncontrollingInterestMember2021-02-012021-10-310000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-02-012021-10-310000088941us-gaap:AdditionalPaidInCapitalMember2021-02-012021-10-310000088941us-gaap:CommonStockMember2021-02-012021-10-310000088941us-gaap:TreasuryStockMember2021-02-012021-10-310000088941us-gaap:CommonStockMember2020-07-260000088941us-gaap:TreasuryStockMember2020-07-260000088941us-gaap:AdditionalPaidInCapitalMember2020-07-260000088941us-gaap:RetainedEarningsMember2020-07-260000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-260000088941us-gaap:ParentMember2020-07-260000088941us-gaap:NoncontrollingInterestMember2020-07-2600000889412020-07-260000088941us-gaap:RetainedEarningsMember2020-07-272020-10-250000088941us-gaap:ParentMember2020-07-272020-10-250000088941us-gaap:NoncontrollingInterestMember2020-07-272020-10-250000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-272020-10-250000088941us-gaap:AdditionalPaidInCapitalMember2020-07-272020-10-250000088941us-gaap:CommonStockMember2020-07-272020-10-250000088941us-gaap:TreasuryStockMember2020-07-272020-10-250000088941us-gaap:CommonStockMember2020-10-250000088941us-gaap:TreasuryStockMember2020-10-250000088941us-gaap:AdditionalPaidInCapitalMember2020-10-250000088941us-gaap:RetainedEarningsMember2020-10-250000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-10-250000088941us-gaap:ParentMember2020-10-250000088941us-gaap:NoncontrollingInterestMember2020-10-2500000889412020-10-250000088941us-gaap:CommonStockMember2020-01-260000088941us-gaap:TreasuryStockMember2020-01-260000088941us-gaap:AdditionalPaidInCapitalMember2020-01-260000088941us-gaap:RetainedEarningsMember2020-01-260000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-260000088941us-gaap:ParentMember2020-01-260000088941us-gaap:NoncontrollingInterestMember2020-01-2600000889412020-01-2600000889412020-01-272020-04-260000088941srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2020-01-260000088941srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:ParentMember2020-01-260000088941srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-01-260000088941us-gaap:RetainedEarningsMember2020-01-272020-10-250000088941us-gaap:ParentMember2020-01-272020-10-250000088941us-gaap:NoncontrollingInterestMember2020-01-272020-10-250000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-272020-10-250000088941us-gaap:AdditionalPaidInCapitalMember2020-01-272020-10-250000088941us-gaap:CommonStockMember2020-01-272020-10-250000088941us-gaap:TreasuryStockMember2020-01-272020-10-250000088941us-gaap:CostOfSalesMember2021-08-022021-10-310000088941us-gaap:CostOfSalesMember2020-07-272020-10-250000088941us-gaap:CostOfSalesMember2021-02-012021-10-310000088941us-gaap:CostOfSalesMember2020-01-272020-10-250000088941us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-08-022021-10-310000088941us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-07-272020-10-250000088941us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-02-012021-10-310000088941us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-272020-10-250000088941smtc:ProductDevelopmentAndEngineeringMember2021-08-022021-10-310000088941smtc:ProductDevelopmentAndEngineeringMember2020-07-272020-10-250000088941smtc:ProductDevelopmentAndEngineeringMember2021-02-012021-10-310000088941smtc:ProductDevelopmentAndEngineeringMember2020-01-272020-10-250000088941us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2021-02-012021-10-310000088941us-gaap:ShareBasedPaymentArrangementNonemployeeMembersmtc:RestrictedStockUnitsRSUsCashSettlementMember2021-02-012021-10-310000088941us-gaap:ShareBasedPaymentArrangementNonemployeeMembersmtc:RestrictedStockUnitsRSUsShareSettlementMember2021-02-012021-10-310000088941us-gaap:PerformanceSharesMember2021-02-012021-10-310000088941us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:PerformanceSharesMember2021-02-012021-10-310000088941us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2021-02-012021-10-310000088941us-gaap:ShareBasedCompensationAwardTrancheThreeMemberus-gaap:PerformanceSharesMember2021-02-012021-10-310000088941smtc:MarketPerformanceSharesMember2021-02-012021-10-31xbrli:pure0000088941us-gaap:ConvertibleDebtSecuritiesMember2021-10-310000088941us-gaap:ConvertibleDebtSecuritiesMember2021-01-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2021-10-310000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2021-10-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2021-10-310000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2021-10-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2021-01-310000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2021-01-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2021-01-310000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2021-01-310000088941us-gaap:TotalReturnSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-10-310000088941us-gaap:FairValueInputsLevel1Memberus-gaap:TotalReturnSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-10-310000088941us-gaap:TotalReturnSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-10-310000088941us-gaap:FairValueInputsLevel3Memberus-gaap:TotalReturnSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-10-310000088941us-gaap:TotalReturnSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-01-310000088941us-gaap:FairValueInputsLevel1Memberus-gaap:TotalReturnSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-01-310000088941us-gaap:TotalReturnSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-01-310000088941us-gaap:FairValueInputsLevel3Memberus-gaap:TotalReturnSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-01-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2021-10-310000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2021-10-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-10-310000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2021-10-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2021-01-310000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2021-01-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-01-310000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2021-01-310000088941us-gaap:FairValueMeasurementsRecurringMember2021-10-310000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-10-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-10-310000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-10-310000088941us-gaap:FairValueMeasurementsRecurringMember2021-01-310000088941us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-01-310000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-01-310000088941us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-01-310000088941srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201613Member2020-01-260000088941smtc:SignalIntegrityMember2021-01-310000088941smtc:WirelessandSensingMember2021-01-310000088941smtc:ProtectionMember2021-01-310000088941smtc:SignalIntegrityMember2021-10-310000088941smtc:WirelessandSensingMember2021-10-310000088941smtc:ProtectionMember2021-10-310000088941us-gaap:DevelopedTechnologyRightsMembersrt:MinimumMember2021-02-012021-10-310000088941srt:MaximumMemberus-gaap:DevelopedTechnologyRightsMember2021-02-012021-10-310000088941us-gaap:DevelopedTechnologyRightsMember2021-10-310000088941us-gaap:DevelopedTechnologyRightsMember2021-01-310000088941us-gaap:DevelopedTechnologyRightsMember2021-08-022021-10-310000088941us-gaap:DevelopedTechnologyRightsMember2020-07-272020-10-250000088941us-gaap:DevelopedTechnologyRightsMember2021-02-012021-10-310000088941us-gaap:DevelopedTechnologyRightsMember2020-01-272020-10-250000088941us-gaap:CustomerRelationshipsMember2021-08-022021-10-310000088941us-gaap:CustomerRelationshipsMember2020-07-272020-10-250000088941us-gaap:CustomerRelationshipsMember2021-02-012021-10-310000088941us-gaap:CustomerRelationshipsMember2020-01-272020-10-250000088941us-gaap:RevolvingCreditFacilityMember2021-10-310000088941us-gaap:RevolvingCreditFacilityMember2021-01-310000088941us-gaap:RevolvingCreditFacilityMember2021-02-012021-05-020000088941us-gaap:RevolvingCreditFacilityMember2021-02-012021-10-310000088941us-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-02-012021-10-310000088941us-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-02-012021-05-020000088941us-gaap:RevolvingCreditFacilityMembersmtc:OneMonthLIBORMember2021-02-012021-10-310000088941us-gaap:RevolvingCreditFacilityMembersmtc:OneMonthLIBORMember2021-02-012021-05-020000088941us-gaap:RevolvingCreditFacilityMember2019-11-070000088941smtc:NoncurrentdeferredtaxassetMember2021-10-310000088941smtc:NoncurrentdeferredtaxassetMember2021-01-310000088941us-gaap:OtherNoncurrentLiabilitiesMember2021-10-310000088941us-gaap:OtherNoncurrentLiabilitiesMember2021-01-310000088941srt:MinimumMemberus-gaap:EnvironmentalIssueMember2021-10-310000088941srt:MaximumMemberus-gaap:EnvironmentalIssueMember2021-10-310000088941us-gaap:EnvironmentalIssueMember2021-02-012021-10-310000088941us-gaap:EnvironmentalIssueMember2021-10-310000088941us-gaap:AccruedLiabilitiesMembersmtc:DeferredCompensationPlanForOfficersAndExecutivesMember2021-10-310000088941us-gaap:AccruedLiabilitiesMembersmtc:DeferredCompensationPlanForOfficersAndExecutivesMember2021-01-310000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-10-310000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-01-310000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMember2021-10-310000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMember2021-01-310000088941us-gaap:OtherAssetsMember2021-10-310000088941us-gaap:OtherAssetsMember2021-01-310000088941us-gaap:CustomerConcentrationRiskMembersmtc:FrontekTechnologyCorporationMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941us-gaap:CustomerConcentrationRiskMembersmtc:FrontekTechnologyCorporationMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941us-gaap:CustomerConcentrationRiskMembersmtc:FrontekTechnologyCorporationMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941us-gaap:CustomerConcentrationRiskMembersmtc:FrontekTechnologyCorporationMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941us-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941us-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941us-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941us-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941smtc:ArrowElectronicsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941smtc:ArrowElectronicsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941smtc:ArrowElectronicsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941smtc:ArrowElectronicsMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941smtc:CEACInternationalLimitedMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941smtc:CEACInternationalLimitedMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941smtc:CEACInternationalLimitedMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941smtc:CEACInternationalLimitedMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersmtc:FrontekTechnologyCorporationMember2021-02-012021-10-310000088941us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersmtc:FrontekTechnologyCorporationMember2021-01-312021-01-310000088941smtc:ArrowElectronicsMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-02-012021-10-310000088941smtc:ArrowElectronicsMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-312021-01-310000088941us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMember2021-02-012021-10-310000088941us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMember2021-01-312021-01-310000088941smtc:CEACInternationalLimitedMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-02-012021-10-310000088941smtc:CEACInternationalLimitedMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-312021-01-31smtc:operating_segmentsmtc:reportable_segment0000088941smtc:SemiconductorProductsGroupMember2021-08-022021-10-310000088941smtc:SemiconductorProductsGroupMember2020-07-272020-10-250000088941smtc:SemiconductorProductsGroupMember2021-02-012021-10-310000088941smtc:SemiconductorProductsGroupMember2020-01-272020-10-250000088941us-gaap:OperatingSegmentsMember2021-08-022021-10-310000088941us-gaap:OperatingSegmentsMember2020-07-272020-10-250000088941us-gaap:OperatingSegmentsMember2021-02-012021-10-310000088941us-gaap:OperatingSegmentsMember2020-01-272020-10-250000088941us-gaap:CorporateNonSegmentMember2021-08-022021-10-310000088941us-gaap:CorporateNonSegmentMember2020-07-272020-10-250000088941us-gaap:CorporateNonSegmentMember2021-02-012021-10-310000088941us-gaap:CorporateNonSegmentMember2020-01-272020-10-250000088941smtc:SignalIntegrityMember2021-08-022021-10-310000088941smtc:SignalIntegrityMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941smtc:SignalIntegrityMember2020-07-272020-10-250000088941smtc:SignalIntegrityMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941smtc:SignalIntegrityMember2021-02-012021-10-310000088941smtc:SignalIntegrityMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941smtc:SignalIntegrityMember2020-01-272020-10-250000088941smtc:SignalIntegrityMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941smtc:WirelessandSensingMember2021-08-022021-10-310000088941smtc:WirelessandSensingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941smtc:WirelessandSensingMember2020-07-272020-10-250000088941smtc:WirelessandSensingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941smtc:WirelessandSensingMember2021-02-012021-10-310000088941smtc:WirelessandSensingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941smtc:WirelessandSensingMember2020-01-272020-10-250000088941smtc:WirelessandSensingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941smtc:ProtectionMember2021-08-022021-10-310000088941smtc:ProtectionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941smtc:ProtectionMember2020-07-272020-10-250000088941smtc:ProtectionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941smtc:ProtectionMember2021-02-012021-10-310000088941smtc:ProtectionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941smtc:ProtectionMember2020-01-272020-10-250000088941smtc:ProtectionMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941us-gaap:SalesChannelThroughIntermediaryMember2021-08-022021-10-310000088941us-gaap:SalesChannelThroughIntermediaryMembersmtc:SalesChannelConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941us-gaap:SalesChannelThroughIntermediaryMember2020-07-272020-10-250000088941us-gaap:SalesChannelThroughIntermediaryMembersmtc:SalesChannelConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941us-gaap:SalesChannelThroughIntermediaryMember2021-02-012021-10-310000088941us-gaap:SalesChannelThroughIntermediaryMembersmtc:SalesChannelConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941us-gaap:SalesChannelThroughIntermediaryMember2020-01-272020-10-250000088941us-gaap:SalesChannelThroughIntermediaryMembersmtc:SalesChannelConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941us-gaap:SalesChannelDirectlyToConsumerMember2021-08-022021-10-310000088941smtc:SalesChannelConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941us-gaap:SalesChannelDirectlyToConsumerMember2020-07-272020-10-250000088941smtc:SalesChannelConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941us-gaap:SalesChannelDirectlyToConsumerMember2021-02-012021-10-310000088941smtc:SalesChannelConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941us-gaap:SalesChannelDirectlyToConsumerMember2020-01-272020-10-250000088941smtc:SalesChannelConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941smtc:SalesChannelConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941smtc:SalesChannelConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941smtc:SalesChannelConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941smtc:SalesChannelConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941us-gaap:GeographicConcentrationRiskMembersrt:NorthAmericaMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941us-gaap:GeographicConcentrationRiskMembersrt:NorthAmericaMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941us-gaap:GeographicConcentrationRiskMembersrt:NorthAmericaMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941us-gaap:GeographicConcentrationRiskMembersrt:NorthAmericaMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941us-gaap:GeographicConcentrationRiskMembersrt:EuropeMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941us-gaap:GeographicConcentrationRiskMembersrt:EuropeMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941us-gaap:GeographicConcentrationRiskMembersrt:EuropeMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941us-gaap:GeographicConcentrationRiskMembersrt:EuropeMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941smtc:ChinaIncludingHongKongMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941smtc:ChinaIncludingHongKongMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941smtc:ChinaIncludingHongKongMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941smtc:ChinaIncludingHongKongMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-08-022021-10-310000088941country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-07-272020-10-250000088941country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-10-310000088941country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2020-01-272020-10-250000088941smtc:StockRepurchaseProgramWIthNoExpirationDateMember2021-08-022021-10-310000088941smtc:StockRepurchaseProgramWIthNoExpirationDateMember2020-07-272020-10-250000088941smtc:StockRepurchaseProgramWIthNoExpirationDateMember2021-02-012021-10-310000088941smtc:StockRepurchaseProgramWIthNoExpirationDateMember2020-01-272020-10-2500000889412021-03-112021-03-110000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMember2021-10-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMember2021-01-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2021-10-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2021-01-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:InterestRateSwapMember2021-10-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:InterestRateSwapMember2021-01-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2021-10-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2021-01-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:InterestRateSwapMember2021-10-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:InterestRateSwapMember2021-01-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-10-310000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-01-310000088941us-gaap:TotalReturnSwapMember2021-10-310000088941us-gaap:TotalReturnSwapMember2021-01-310000088941us-gaap:TotalReturnSwapMember2021-08-022021-10-310000088941us-gaap:TotalReturnSwapMember2021-02-012021-10-31
falseQ1000008894101/292023P1YP2Y0.33330.33330.3333--0--http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent00000889412022-01-312022-05-0100000889412022-05-27xbrli:sharesiso4217:USD00000889412021-02-012021-05-02iso4217:USDxbrli:shares0000088941us-gaap:InterestRateSwapMember2022-01-312022-05-010000088941us-gaap:InterestRateSwapMember2021-02-012021-05-0200000889412022-05-0100000889412022-01-300000088941us-gaap:CommonStockMember2022-01-300000088941us-gaap:TreasuryStockMember2022-01-300000088941us-gaap:AdditionalPaidInCapitalMember2022-01-300000088941us-gaap:RetainedEarningsMember2022-01-300000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-300000088941us-gaap:ParentMember2022-01-300000088941us-gaap:NoncontrollingInterestMember2022-01-300000088941us-gaap:RetainedEarningsMember2022-01-312022-05-010000088941us-gaap:ParentMember2022-01-312022-05-010000088941us-gaap:NoncontrollingInterestMember2022-01-312022-05-010000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-312022-05-010000088941us-gaap:AdditionalPaidInCapitalMember2022-01-312022-05-010000088941us-gaap:CommonStockMember2022-01-312022-05-010000088941us-gaap:TreasuryStockMember2022-01-312022-05-010000088941us-gaap:CommonStockMember2022-05-010000088941us-gaap:TreasuryStockMember2022-05-010000088941us-gaap:AdditionalPaidInCapitalMember2022-05-010000088941us-gaap:RetainedEarningsMember2022-05-010000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-05-010000088941us-gaap:ParentMember2022-05-010000088941us-gaap:NoncontrollingInterestMember2022-05-010000088941us-gaap:CommonStockMember2021-01-310000088941us-gaap:TreasuryStockMember2021-01-310000088941us-gaap:AdditionalPaidInCapitalMember2021-01-310000088941us-gaap:RetainedEarningsMember2021-01-310000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-310000088941us-gaap:ParentMember2021-01-310000088941us-gaap:NoncontrollingInterestMember2021-01-3100000889412021-01-310000088941us-gaap:RetainedEarningsMember2021-02-012021-05-020000088941us-gaap:ParentMember2021-02-012021-05-020000088941us-gaap:NoncontrollingInterestMember2021-02-012021-05-020000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-02-012021-05-020000088941us-gaap:AdditionalPaidInCapitalMember2021-02-012021-05-020000088941us-gaap:CommonStockMember2021-02-012021-05-020000088941us-gaap:TreasuryStockMember2021-02-012021-05-020000088941us-gaap:CommonStockMember2021-05-020000088941us-gaap:TreasuryStockMember2021-05-020000088941us-gaap:AdditionalPaidInCapitalMember2021-05-020000088941us-gaap:RetainedEarningsMember2021-05-020000088941us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-05-020000088941us-gaap:ParentMember2021-05-020000088941us-gaap:NoncontrollingInterestMember2021-05-0200000889412021-05-020000088941smtc:HighReliabilityDiscreteDiodesAndAssembliesBusinessMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2022-05-010000088941us-gaap:CostOfSalesMember2022-01-312022-05-010000088941us-gaap:CostOfSalesMember2021-02-012021-05-020000088941us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-312022-05-010000088941us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-02-012021-05-020000088941smtc:ProductDevelopmentAndEngineeringMember2022-01-312022-05-010000088941smtc:ProductDevelopmentAndEngineeringMember2021-02-012021-05-020000088941us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-312022-05-010000088941us-gaap:PerformanceSharesMember2022-01-312022-05-010000088941us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-312022-05-010000088941us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-01-312022-05-010000088941us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2022-01-312022-05-01xbrli:pure0000088941us-gaap:ShareBasedPaymentArrangementNonemployeeMembersmtc:RestrictedStockUnitsRSUsCashSettlementMember2022-01-312022-05-010000088941us-gaap:ShareBasedPaymentArrangementNonemployeeMembersmtc:RestrictedStockUnitsRSUsShareSettlementMember2022-01-312022-05-010000088941smtc:MarketPerformanceSharesMember2022-01-312022-05-010000088941us-gaap:ConvertibleDebtSecuritiesMember2022-05-010000088941us-gaap:ConvertibleDebtSecuritiesMember2022-01-300000088941us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-05-010000088941us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-05-010000088941us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-05-010000088941us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-05-010000088941us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-01-300000088941us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-01-300000088941us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-01-300000088941us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-300000088941us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-05-010000088941us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-05-010000088941us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-05-010000088941us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-05-010000088941us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-01-300000088941us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-01-300000088941us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-01-300000088941us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-300000088941us-gaap:FairValueMeasurementsRecurringMember2022-05-010000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-05-010000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-05-010000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-05-010000088941us-gaap:FairValueMeasurementsRecurringMember2022-01-300000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-01-300000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-01-300000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-300000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:TotalReturnSwapMember2022-05-010000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:TotalReturnSwapMember2022-05-010000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:TotalReturnSwapMemberus-gaap:FairValueInputsLevel2Member2022-05-010000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:TotalReturnSwapMemberus-gaap:FairValueInputsLevel3Member2022-05-010000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:TotalReturnSwapMember2022-01-300000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:TotalReturnSwapMember2022-01-300000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:TotalReturnSwapMemberus-gaap:FairValueInputsLevel2Member2022-01-300000088941us-gaap:FairValueMeasurementsRecurringMemberus-gaap:TotalReturnSwapMemberus-gaap:FairValueInputsLevel3Member2022-01-300000088941smtc:SignalIntegrityMember2022-01-300000088941smtc:WirelessandSensingMember2022-01-300000088941smtc:ProtectionMember2022-01-300000088941smtc:SignalIntegrityMember2022-01-312022-05-010000088941smtc:WirelessandSensingMember2022-01-312022-05-010000088941smtc:ProtectionMember2022-01-312022-05-010000088941smtc:SignalIntegrityMember2022-05-010000088941smtc:WirelessandSensingMember2022-05-010000088941smtc:ProtectionMember2022-05-010000088941us-gaap:DevelopedTechnologyRightsMembersrt:MinimumMember2022-01-312022-05-010000088941us-gaap:DevelopedTechnologyRightsMembersrt:MaximumMember2022-01-312022-05-010000088941us-gaap:DevelopedTechnologyRightsMember2022-05-010000088941us-gaap:DevelopedTechnologyRightsMember2022-01-300000088941us-gaap:DevelopedTechnologyRightsMember2022-01-312022-05-010000088941us-gaap:DevelopedTechnologyRightsMember2021-02-012021-05-020000088941us-gaap:RevolvingCreditFacilityMember2022-05-010000088941us-gaap:RevolvingCreditFacilityMember2022-01-300000088941us-gaap:RevolvingCreditFacilityMember2022-01-312022-05-010000088941us-gaap:RevolvingCreditFacilityMember2021-11-012022-01-300000088941us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMember2022-01-312022-05-010000088941us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMember2021-11-012022-01-300000088941smtc:OneMonthLIBORMemberus-gaap:RevolvingCreditFacilityMember2022-01-312022-05-010000088941smtc:OneMonthLIBORMemberus-gaap:RevolvingCreditFacilityMember2021-11-012022-01-300000088941us-gaap:RevolvingCreditFacilityMember2019-11-070000088941smtc:NoncurrentdeferredtaxassetMember2022-05-010000088941smtc:NoncurrentdeferredtaxassetMember2022-01-300000088941us-gaap:OtherNoncurrentLiabilitiesMember2022-05-010000088941us-gaap:OtherNoncurrentLiabilitiesMember2022-01-300000088941us-gaap:EnvironmentalIssueMembersrt:MinimumMember2022-05-010000088941us-gaap:EnvironmentalIssueMembersrt:MaximumMember2022-05-010000088941us-gaap:EnvironmentalIssueMember2022-01-312022-05-010000088941us-gaap:EnvironmentalIssueMember2022-05-010000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMemberus-gaap:AccruedLiabilitiesMember2022-05-010000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMemberus-gaap:AccruedLiabilitiesMember2022-01-300000088941us-gaap:OtherNoncurrentLiabilitiesMembersmtc:DeferredCompensationPlanForOfficersAndExecutivesMember2022-05-010000088941us-gaap:OtherNoncurrentLiabilitiesMembersmtc:DeferredCompensationPlanForOfficersAndExecutivesMember2022-01-300000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMember2022-05-010000088941smtc:DeferredCompensationPlanForOfficersAndExecutivesMember2022-01-300000088941us-gaap:OtherAssetsMember2022-05-010000088941us-gaap:OtherAssetsMember2022-01-300000088941us-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMemberus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941us-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMemberus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941smtc:FrontekTechnologyCorporationMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941smtc:FrontekTechnologyCorporationMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941smtc:CEACInternationalLimitedMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941smtc:CEACInternationalLimitedMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941us-gaap:AccountsReceivableMembersmtc:FrontekTechnologyCorporationMemberus-gaap:CustomerConcentrationRiskMember2022-01-312022-05-010000088941us-gaap:AccountsReceivableMembersmtc:FrontekTechnologyCorporationMemberus-gaap:CustomerConcentrationRiskMember2021-01-312021-01-310000088941us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMember2022-01-312022-05-010000088941us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembersmtc:TrendTekTechnologyLtdAndAffiliatesMember2021-01-312021-01-310000088941us-gaap:AccountsReceivableMembersmtc:CEACInternationalLimitedMemberus-gaap:CustomerConcentrationRiskMember2022-01-312022-05-010000088941us-gaap:AccountsReceivableMembersmtc:CEACInternationalLimitedMemberus-gaap:CustomerConcentrationRiskMember2021-01-312021-01-31smtc:segment0000088941smtc:SemiconductorProductsGroupMember2022-01-312022-05-010000088941smtc:SemiconductorProductsGroupMember2021-02-012021-05-020000088941smtc:SystemProtectionGroupMember2022-01-312022-05-010000088941smtc:SystemProtectionGroupMember2021-02-012021-05-020000088941smtc:UnallocatedMember2022-01-312022-05-010000088941smtc:UnallocatedMember2021-02-012021-05-020000088941smtc:SignalIntegrityMember2022-01-312022-05-010000088941us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembersmtc:SignalIntegrityMember2022-01-312022-05-010000088941smtc:SignalIntegrityMember2021-02-012021-05-020000088941us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembersmtc:SignalIntegrityMember2021-02-012021-05-020000088941smtc:WirelessandSensingMember2022-01-312022-05-010000088941us-gaap:ProductConcentrationRiskMembersmtc:WirelessandSensingMemberus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941smtc:WirelessandSensingMember2021-02-012021-05-020000088941us-gaap:ProductConcentrationRiskMembersmtc:WirelessandSensingMemberus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941smtc:ProtectionMember2022-01-312022-05-010000088941us-gaap:ProductConcentrationRiskMembersmtc:ProtectionMemberus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941smtc:ProtectionMember2021-02-012021-05-020000088941us-gaap:ProductConcentrationRiskMembersmtc:ProtectionMemberus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941us-gaap:SalesChannelThroughIntermediaryMember2022-01-312022-05-010000088941us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:SalesRevenueNetMembersmtc:SalesChannelConcentrationRiskMember2022-01-312022-05-010000088941us-gaap:SalesChannelThroughIntermediaryMember2021-02-012021-05-020000088941us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:SalesRevenueNetMembersmtc:SalesChannelConcentrationRiskMember2021-02-012021-05-020000088941us-gaap:SalesChannelDirectlyToConsumerMember2022-01-312022-05-010000088941us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:SalesRevenueNetMembersmtc:SalesChannelConcentrationRiskMember2022-01-312022-05-010000088941us-gaap:SalesChannelDirectlyToConsumerMember2021-02-012021-05-020000088941us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:SalesRevenueNetMembersmtc:SalesChannelConcentrationRiskMember2021-02-012021-05-020000088941us-gaap:SalesRevenueNetMembersmtc:SalesChannelConcentrationRiskMember2022-01-312022-05-010000088941us-gaap:SalesRevenueNetMembersmtc:SalesChannelConcentrationRiskMember2021-02-012021-05-020000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:AsiaPacificMember2022-01-312022-05-010000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:AsiaPacificMember2021-02-012021-05-020000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:NorthAmericaMember2022-01-312022-05-010000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:NorthAmericaMember2021-02-012021-05-020000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:EuropeMember2022-01-312022-05-010000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMembersrt:EuropeMember2021-02-012021-05-020000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941smtc:ChinaIncludingHongKongMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941smtc:ChinaIncludingHongKongMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2022-01-312022-05-010000088941us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2021-02-012021-05-020000088941smtc:StockRepurchaseProgramWIthNoExpirationDateMember2022-01-312022-05-010000088941smtc:StockRepurchaseProgramWIthNoExpirationDateMember2021-02-012021-05-0200000889412021-03-112021-03-110000088941us-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-05-010000088941us-gaap:InterestRateSwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-300000088941us-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-05-010000088941us-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-300000088941us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2022-05-010000088941us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2022-01-300000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2022-05-010000088941us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMember2022-01-300000088941us-gaap:TotalReturnSwapMember2022-05-010000088941us-gaap:TotalReturnSwapMember2022-01-300000088941us-gaap:TotalReturnSwapMember2022-01-312022-05-010000088941us-gaap:TotalReturnSwapMember2021-02-012021-05-020000088941us-gaap:SubsequentEventMembersmtc:MicrossComponentsIncMembersmtc:HighReliabilityDiscreteDiodesAndAssembliesBusinessMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-05-03

| | | |
| |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________
FORM 10-Q
____________________________________
(Mark One)
| | | | | | |
| ☒ | Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended May 1, 2022
or
| | | | | | |
| ☐ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
Commission File Number 001-06395
____________________________________
SEMTECH CORPORATION
(Exact name of registrant as specified in its charter)
____________________________________
| | | | | | | | | |
| | | |
| Delaware | | 95-2119684 |
| (State or other jurisdiction of | | (I.R.S. Employer |
| incorporation or organization) | | Identification No.) |

200 Flynn Road, Camarillo, California, 93012-8790
(Address of principal executive offices, Zip Code)

Registrant's telephone number, including area code: (805) 498-2111
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| Common Stock par value $0.01 per share | | SMTC | | The Nasdaq Global Select Market |
____________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | | | | | | | | |
| Large accelerated filer | | x | | Accelerated filer | | ☐ |
| | | | |
| Non-accelerated filer | | ☐ | | Smaller reporting company | | ☐ |
| | | | | | | |
| | | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Number of shares of common stock, $0.01 par value per share, outstanding at May 27, 2022: 63,477,783
| | | |
| |



SEMTECH CORPORATION
INDEX TO FORM 10-Q
FOR THE QUARTER ENDED MAY 1, 2022

| | | | | | |
| PART I - FINANCIAL INFORMATION | 3 |
| | |
| ITEM 1. Financial Statements | 4 |
| | |
| ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 28 |
| | |
| ITEM 3. Quantitative and Qualitative Disclosures About Market Risk | 36 |
| | |
| ITEM 4. Controls and Procedures | 37 |
| | |
| PART II - OTHER INFORMATION | 38 |
| | |
| ITEM 1. Legal Proceedings | 38 |
| | |
| ITEM 1A. Risk Factors | 38 |
| | |
| ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds | 38 |
| | |
| ITEM 3. Defaults Upon Senior Securities | 38 |
| | |
| ITEM 4. Mine Safety Disclosures | 38 |
| | |
| ITEM 5. Other Information | 38 |
| | |
| ITEM 6. Exhibits | 39 |
2


Unless the context otherwise requires, the use of the terms "Semtech," "the Company," "we," "us" and "our" in this Quarterly Report on Form 10-Q refers to Semtech Corporation and, as applicable, its consolidated subsidiaries. This Quarterly Report on Form 10-Q may contain references to the Company's trademarks and to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Quarterly Report on Form 10-Q, including logos, artwork and other visual displays, may appear without the ® or TM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies' trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other company.
Special Note Regarding Forward-Looking and Cautionary Statements
This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended, based on our current expectations, estimates and projections about our operations, industry, financial condition, performance, results of operations, and liquidity. Forward-looking statements are statements other than historical information or statements of current condition and relate to matters such as future financial performance, future operational performance, the anticipated impact of specific items on future earnings, and our plans, objectives and expectations. Statements containing words such as "may," "believe," "anticipate," "expect," "intend," "plan," "project," "estimate," "should," "will," "designed to," "projections," or "business outlook," or other similar expressions constitute forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that could cause actual results and events to differ materially from those projected. Potential factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: the uncertainty surrounding the impact and duration of supply chain constraints and any associated disruptions; the uncertainty surrounding the impact and duration of the COVID-19 pandemic; on global economic conditions and on the Company's business and results of operations, including as a result of any regulatory vaccine mandate on our workforce, which could result in increased labor attrition and disruption, as well as difficulty securing future labor needs; export restrictions and laws affecting the Company's trade and investments and tariffs or the occurrence of trade wars; worldwide economic and political disruptions as a result of the current conflict between Russia and Ukraine; competitive changes in the marketplace including, but not limited to, the pace of growth or adoption rates of applicable products or technologies; downturns in the business cycle; decreased average selling prices of the Company's products; the Company's reliance on a limited number of suppliers and subcontractors for components and materials; changes in projected or anticipated end-user markets; export restrictions and laws affecting the Company's trade and investments including with respect to Huawei and certain of its affiliates and other entities identified by the U.S. government, and tariffs or the occurrence of trade wars; and the Company's ability to forecast and achieve anticipated net sales and earnings estimates in light of periodic economic uncertainty, including impacts arising from Asian, European and global economic dynamics.
Additionally, forward-looking statements should be considered in conjunction with the cautionary statements contained in this Quarterly Report on Form 10-Q, including, without limitation, information under the captions "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk factors and additional Factors" that accompany the related forward-looking statements in this Quarterly Report on Form 10-Q, in our dynamic; and those factors set forth under "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2021 including, without limitation, information under the caption "Risk Factors," and in our other filings with the U.S.30, 2022 filed with the Securities and Exchange Commission (the "SEC") on March 16, 2022, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with SEC. In light of the significant risks and uncertainties inherent in the forward-looking information included herein that may cause actual performance and results to differ materially from those predicted, any such forward-looking information should not be regarded as representations or guarantees by the Company of future performance or results, or that its objectives or plans will be achieved, or that any of its operating expectations or financial forecasts will be realized. Reported results should not be considered an indication of future performance. Investors are cautioned not to place undue reliance on any forward-looking information contained herein, which reflect management's analysis only as of the date hereof. Except as required by law, the Company assumes no obligation to publicly release the results of any update or revision to any forward-looking statement that may be made to reflect new information, events or circumstances after the date hereof or to reflect the occurrence of unanticipated or future events, or otherwise.
The factors noted above, and the risks included in our SEC filings, may be increased or intensified as a result of the COVID-19 pandemic. The extent to which the COVID-19 pandemic ultimately impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted. In addition to regarding forward-looking statements with caution, you should consider that the preparation of the consolidated financial statements requires us to draw conclusions and make interpretations, judgments, assumptions and estimates with respect to certain factual, legal, and accounting matters. Our consolidated financial statements might have been materially impacted if we had reached different conclusions or made different interpretations, judgments, assumptions or estimates.
3


PART I - FINANCIAL INFORMATION

ITEM 1.Financial Statements

SEMTECH CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)
(unaudited)

| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| | May 1, 2022 | | May 2, 2021 | | | | |
| Net sales | $ | 194,932 | | | $ | 154,082 | | | $ | 550,308 | | | $ | 430,444 | |
| Net sales | $ | 202,149 | | | $ | 170,372 | | | | | |
| Cost of sales | 71,243 | | | 60,021 | | | 206,326 | | | 167,371 | |
| Cost of sales | 71,896 | | | 65,511 | | | | | |
| Gross profit | 123,689 | | | 94,061 | | | 343,982 | | | 263,073 | |
| Gross profit | 130,253 | | | 104,861 | | | | | |
| Operating costs and expenses: | | | | | | | |
| Selling, general and administrative | 47,621 | | | 42,891 | | | 128,402 | | |115,746 | |43,364 | | | 38,804 | | | | | |
| Product development and engineering | 37,346 | | | 27,890 | | | 109,633 | | |84,696 | |38,789 | | | 36,790 | | | | | |
| Intangible amortization | 1,298 | | | 1,798 | | | 3,894 | | | 6,658 | |
| Intangible amortization | 1,048 | | | 1,298 | | | | | |

| | | | | | | | |

| Changes in the fair value of contingent earn-out obligations | -| | | | | - | | | - | | | (33) | |
| | | | | | | | |
| Total operating costs and expenses | 86,265 | | | 72,579 | | | 241,929 | | |207,067 | |83,201 | | | 76,892 | | | | | |
| Operating income | 37,424 | | | 21,482 | | | 102,053 | | |56,006 | |
| Operating income | 47,052 | | | 27,969 | | | | | |
| Interest expense | (1,233) | | | (1,008) | | | (3,617) | | | (3,819) | |
| Interest expense | (1,197) | | | (1,199) | | | | | |
| Non-operating income, (expense), net | 105 | | | (236) | | | 412 | | |11 | |
| Non-operating income, net | 262 | | | 94 | | | | | |
| Investment impairments and credit loss reserves | (216) | | | (335) | | | (930) | | |(5,450) | |(24) | | | (246) | | | | | |
| Income before taxes and equity in net gains of equity method investments | 36,080 | | | 19,903 | | | 97,918 | | | 46,748 | |46,093 | | | 26,618 | | | | | |
| Provision for income taxes | 3,018 | | | 1,580 | | | 9,179 | | |2,523 | |
| Provision for income taxes | 8,069 | | | 3,198 | | | | | |
| Net income before equity in net gains of equity method investments | 33,062 | | | 18,323 | | | 88,739 | | |44,225 | |38,024 | | | 23,420 | | | | | |
| Equity in net gains of equity method investments | 1,363 | | | 159 | | | 2,115 | | |11 | |24 | | | 78 | | | | | |
| Net income | 34,425 | | | 18,482 | | | 90,854 | | | 44,236 | |
| Net income | 38,048 | | | 23,498 | | | | | |
| Net loss attributable to noncontrolling interest | (2) | | | (5) | | | (6) | | |(11) | |(1) | | | (2) | | | | | |
| Net income attributable to common stockholders | $ | 34,427 | | | $ | 18,487 | | | $ | 90,860 | | |$ | 44,247 | |38,049 | | | $ | 23,500 | | | | | |
| Earnings per share: | | | | | | | |
| Basic | $ | 0.53 | | | $ | 0.28 | | | $ | 1.40 | | | $ | 0.68 | |
| Basic | $ | 0.59 | | | $ | 0.36 | | | | | |
| Diluted | $ | 0.53 | | | $ | 0.28 | | | $ | 1.38 | | | $ | 0.67 | |
| Diluted | $ | 0.59 | | | $ | 0.36 | | | | | |
| Weighted-average number of shares used in computing earnings per share: | | | | | | | |
| Basic | 64,546 | | | 65,136 | | | 64,786 | | |65,270 | |
| Basic | 63,950 | | | 65,089 | | | | | |
| Diluted | 65,299 | | | 65,967 | | | 65,664 | | |66,050 | |
| Diluted | 64,553 | | | 66,110 | | | | | |
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
4


SEMTECH CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
(unaudited)

| | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| | May 1, 2022 | | May 2, 2021 | | | | |
| Net income | $ | 34,425 | | | $ | 18,482 | | | $ | 90,854 | | | $ | 44,236 | |
| Net income | $ | 38,048 | | | $ | 23,498 | | | | | |
| Other comprehensive income, (loss), net: | | | | | | | |
| Unrealized gain on foreign currency cash flow hedges, net | - | | | 173 | | | - | | | 531 | |
| | | | | | | | |
| Reclassifications of realized gain on foreign currency cash flow hedges, net to net income | - | | | (244) | | | - | | | (238) | |
| | | | | | | | |
| Unrealized (loss) gain on interest rate cash flow hedges, net | (388) | | | (82) | | | 341 | | |(1,702) | |1,258 | | | 464 | | | | | |
| Reclassifications of realized loss (gain) on interest rate cash flow hedges, net to net income | 923 | | | 173 | | | 557 | | | 246 | |119 | | | (179) | | | | | |
| Unrealized gain on available-for-sale securities | -| | | | | - | | | - | | | 386 | |
| Reclassification of realized gain on available-for-sale securities, net to net income | -| | | | | - | | | - | | | (757) | |
| Change in defined benefit plans, net | 158 | | | 202 | | | 472 | | |581 | |23 | | | 155 | | | | | |
| | | | | | | | |
| Other comprehensive income, (loss), net | 693 | | | 222 | | | 1,370 | | | (953) | |
| Other comprehensive income, net | 1,400 | | | 440 | | | | | |
| Comprehensive income | $ | 35,118 | | | $ | 18,704 | | | $ | 92,224 | | | $ | 43,283 | |
| Comprehensive income | $ | 39,448 | | | $ | 23,938 | | | | | |
| Comprehensive loss attributable to noncontrolling interest | (2) | | | (5) | | | (6) | | |(11) | |(1) | | | (2) | | | | | |
| Comprehensive income attributable to common stockholders | $ | 35,120 | | | $ | 18,709 | | | $ | 92,230 | | | $ | 43,294 | |39,449 | | | $ | 23,940 | | | | | |
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.









5


SEMTECH CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
(unaudited)
| | | | | | | | | | | | |
| | October 31, 2021 | | January 31, 2021 |
| | May 1, 2022 | | January 30, 2022 |
| Assets | | | |
| Current assets: | | | |
| Cash and cash equivalents | $ | 275,184 | | | $ | 279,601 | |
| Accounts receivable, less allowances of $763 and $721, respectively | 74,313 | | | 70,433 | |$692 and $747, respectively | 66,360 | | | 71,507 | |
| Inventories | 105,159 | | | 87,494 | |
| Inventories | 106,901 | | | 114,003 | |
| Prepaid taxes | 11,738 | | |22,083 | || Prepaid taxes | 2,442 | | | 5,983 | |
| Assets held for sale | 9,065 | | | - | |

| Other current assets | 28,548 | | | 25,827 | |
| Other current assets | 35,471 | | | 31,201 | |
| Total current assets | 496,357 | | | 474,728 | |
| Total current assets | 495,423 | | | 502,295 | |
| Non-current assets: | | | |
| Property, plant and equipment, net of accumulated depreciation of $248,988 and $233,779, respectively | 130,734 | | | 130,934 | |$247,403 and $254,764, respectively | 133,590 | | | 134,940 | |
| Deferred tax assets | 26,928 | | | 25,483 | |
| Deferred tax assets | 25,643 | | | 27,803 | |
| Goodwill | 350,306 | | | 351,141 | |
| Other intangible assets, net | 5,756 | | | 6,804 | |
| Other assets | 108,288 | | | 88,070 | |
| Other assets | 105,198 | | | 107,928 | |
| TOTAL ASSETS | $ | 1,121,300 | | | $ | 1,082,102 | |
| TOTAL ASSETS | $ | 1,115,916 | | | $ | 1,130,911 | |
| Liabilities and Equity | | | |
| Current liabilities: | | | |
| Accounts payable | $ | 46,426 | | | $ | 50,189 | |
| Accounts payable | $ | 48,381 | | | $ | 50,695 | |
| Accrued liabilities | 77,483 | | | 59,384 | |
| Accrued liabilities | 60,793 | | | 77,704 | |
| Liabilities held for sale | 1,242 | | | - | |
| Total current liabilities | 110,416 | | | 128,399 | |
| Non-current liabilities: | | | |
| Deferred tax liabilities | 1,066 | | | 1,132 | |
| Long term debt | 175,556 | | | 179,195 | |
| Long term debt | 181,797 | | | 171,676 | |
| Other long-term liabilities | 87,464 | | | 91,929 | |
| | | | |
| Commitments and contingencies (Note 12) | | | |
| | | | |
| Stockholders' equity: | | | |
| Common stock, $0.01 par value, 250,000,000 shares authorized, 78,136,144 issued and 63,466,933 outstanding and 78,136,144 issued and 64,098,565 outstanding, respectively | 785 | | | 785 | |
| Treasury stock, at cost, 13,736,903 shares and 13,037,765 shares, respectively | (519,610) | | | (438,798) | |
| Treasury stock, at cost, 14,669,211 shares and 14,037,579 shares, respectively | (596,187) | | | (549,942) | |
| Additional paid-in capital | 496,151 | | | 491,956 | |
| Retained earnings | 762,056 | | | 671,196 | |
| Retained earnings | 834,909 | | | 796,860 | |
| Accumulated other comprehensive loss | (675) | | | (2,075) | |
| Total stockholders' equity | 734,983 | | | 737,584 | |
| | | | |
| Noncontrolling interest | 190 | | | 191 | |
| Total equity | 718,398 | | | 698,953 | |
| Total equity | 735,173 | | | 737,775 | |
| TOTAL LIABILITIES AND EQUITY | $ | 1,115,916 | | | $ | 1,130,911 | |
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
6


SEMTECH CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands, except share data)
(unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended May 1, 2022 |
| | Common Stock | | | | | | | | Accumulated Other Comprehensive Loss | | | | | | |
| | Number of Shares Outstanding | | Amount | | Treasury Stock, at Cost | | Additional Paid-in Capital | | Retained Earnings | | | Stockholders' Equity | | Noncontrolling Interest | | Total Equity |
| Balance at August 1, 2021 | 64,396,741 | | | $ | 785 | | | $ | (499,199) | | | $ | 486,693 | | | $ | 727,629 | | | $ | (7,491) | | | $ | 708,417 | | | $ | 206 | | | $ | 708,623 | |
| | | | | | | | | | | | | | | | | | |
| Net income | - | | | - | | | - | | | - | | | 34,427 | | | - | | | 34,427 | | | (2) | | | 34,425 | |
| Other comprehensive income | - | | | - | | | - | | | - | | | - | | | 693 | | | 693 | | | - | | | 693 | |
| Share-based compensation | - | | | - | | | - | | | 13,289 | | | - | | | - | | | 13,289 | | | - | | | 13,289 | |
| Repurchase of common stock | (387,163) | | | - | | | (30,000) | | | - | | | - | | | - | | | (30,000) | | | - | | | (30,000) | |
| Treasury stock reissued | 389,663 | | | - | | | 9,589 | | | (18,221) | | | - | | | - | | | (8,632) | | | - | | | (8,632) | |
| Balance at October 31, 2021 | 64,399,241 | | | $ | 785 | | | $ | (519,610) | | | $ | 481,761 | | | $ | 762,056 | | | $ | (6,798) | | | $ | 718,194 | | | $ | 204 | | | $ | 718,398 | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Nine Months Ended October 31, 2021 |
| | Common Stock | | | | | | | | | | | | | | |
| | Number of Shares Outstanding | | Amount | | Treasury Stock, at Cost | | Additional Paid-in Capital | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Stockholders' Equity | | Noncontrolling Interest | | Total Equity |
| Balance at January 31, 2021 | 65,098,379 | | | $ | 785 | | | $ | (438,798) | | | $ | 473,728 | | | $ | 671,196 | | | $ | (8,168) | | | $ | 698,743
| Balance at January 30, 2022 | 64,098,565 | | | $ | 785 | | | $ | (549,942) | | | $ | 491,956 | | | $ | 796,860 | | | $ | (2,075) | | | $ | 737,584 | | | $ | 191 | | | $ | 737,775 | |
| | | | | | | | | | | | | | | | | | |
| Net income | - | | | - | | | - | | | - | | | 90,860 | | | - | | | 90,860 | | | (6) | | | 90,854 | |38,049 | | | - | | | 38,049 | | | (1) | | | 38,048 | |
| Other comprehensive income | - | | | - | | | - | | | - | | | - | | | 1,370 | | | 1,370 | | | - | | | 1,370 | |1,400 | | | 1,400 | | | - | | | 1,400
| | | | | | | | | | | | | | | | | ||
| Share-based compensation | - | | | - | | | - | | | 12,103 | | | - | | | - | | | 12,103 | | | - | | | 12,103 | |
| Repurchase of common stock | (1,387,624) | | | - | | | (97,000) | Repurchase of common stock | (762,093) | | | - | | | (50,000) | | | - | | | - | | | - | | | (50,000) | | | - | | | (50,000) | |
| Treasury stock reissued | 688,486 | | | - | | | 16,188 | | | (29,786) | | | - | | | - | | | (13,598) | | | - | | | (13,598) | |
| Treasury stock reissued | 130,461 | | | - | | | 3,755 | | | (7,908) | | | - | | | - | | | (4,153) | | | - | | | (4,153) | |
| Balance at October 31, 2021 | 64,399,241 | | | $ | 785 | | | $ | (519,610) | | | $ | 481,761 | | | $ | 762,056 | | | $ | (6,798) | | | $ | 718,194 | Balance at May 1, 2022 | 63,466,933 | | | $ | 785 | | | $ | (596,187) | | | $ | 496,151 | | | $ | 834,909 | | | $ | (675) | | | $ | 734,983 | | | $ | 190 | | | $ | 735,173 | |
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
7


SEMTECH CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (CONTINUED)
(in thousands, except share data)
(unaudited)

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended May 2, 2021 |
| | Common Stock | | | | | | Accumulated Other Comprehensive Loss | | | | | | |
| | Number of Shares Outstanding | | Amount | | Treasury Stock, at Cost | | Additional Paid-in Capital | | Retained Earnings | | | Stockholders' Equity | | Noncontrolling Interest | | Total Equity |
| Balance at July 26, 2020 | 65,019,501 | | | $ | 785 | | | $ | (424,095) | | | $ | 471,091 | | | $ | 637,053 | | | $ | (7,341) | | | $ | 677,493 | Balance at January 31, 2021 | 65,098,379 | | | $ | 785 | | | $ | (438,798) | | | $ | 473,728 | | | $ | 671,196 | | | $ | (8,168) | | | $ | 698,743 | | | $ | 210 | | | $ | 698,953 | |
| Net income | - | | | - | | | - | | | - | | | 18,487 | | | - | | | 18,487 | | | (5) | | | 18,482 | |23,500 | | | - | | | 23,500 | | | (2) | | | 23,498 | |
| Other comprehensive income | - | | | - | | | - | | | - | | | - | | | 440 | | | 440 | | | - | | | 440 | |
| | | | | | | | | | | | | | | | | | |
| Share-based compensation | - | | | - | | | - | | | 12,196 | | | - | | | - | | | 12,196 | | | - | | | 12,196 | |
| Repurchase of common stock | (360,942) | | | - | | | (25,000) | | | - | | | - | | | - | | | (25,000) | | | - | | | (25,000) | |
| Treasury stock reissued | 386,713 | | | - | | | 9,895 | | | (17,993) | | | - | | | - | | | (8,098) | | | - | | | (8,098) | |
| Treasury stock reissued | 160,483 | | | - | | | 3,549 | | | (9,151) | | | - | | | - | | | (5,602) | | | - | | | (5,602) | |
| Balance at October 25, 2020 | 64,966,293 | | | $ | 785 | | | $ | (438,246) | | | $ | 465,431 | | | $ | 655,540 | | | $ | (7,119) | | | $ | 676,391 | Balance at May 2, 2021 | 64,897,920 | | | $ | 785 | | | $ | (460,249) | | | $ | 476,773 | | | $ | 694,696 | | | $ | (7,728) | | | $ | 704,277 | | | $ | 208 | | | $ | 676,626 | |

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Nine Months Ended October 25, 2020 |
| | Common Stock | | | | | | | | | | Accumulated Other Comprehensive Loss | | | | | | |
| | Number of Shares Outstanding | | Amount | | Treasury Stock, at Cost | | Additional Paid-in Capital | | Retained Earnings | | | | | Stockholders' Equity | | Noncontrolling Interest | | Total Equity |
| Balance at January 26, 2020 | 65,758,115 | | | $ | 785 | | | $ | (387,851) | | | $ | 458,579 | | | $ | 611,607 | | | | | $ | (6,166) | | | $ | 676,954 | | | $ | 246 | | | $ | 677,200 | |
| Cumulative-effect adjustment to beginning balance from adoption of ASU 2016-13 | - | | | - | | | - | | | - | | | (314) | | | | | - | | | (314) | | | - | | | (314) | |
| Net income | - | | | - | | | - | | | - | | | 44,247 | | | | | - | | | 44,247 | | | (11) | | | 44,236 | |
| Other comprehensive loss | - | | | - | | | - | | | - | | | - | | | | | (953) | | | (953) | | | - | | | (953) | |
| | | | | | | | | | | | | | | | | | | | |
| Share-based compensation | - | | | - | | | - | | | 34,757 | | | - | | | | | - | | | 34,757 | | | - | | | 34,757 | |
| Repurchase of common stock | (1,527,834) | | | - | | | (66,433) | | | - | | | - | | | | | - | | | (66,433) | | | - | | | (66,433) | |
| Treasury stock reissued | 736,012 | | | - | | | 16,038 | | | (27,905) | | | - | | | | | - | | | (11,867) | | | - | | | (11,867) | |
| Balance at October 25, 2020 | 64,966,293 | | | $ | 785 | | | $ | (438,246) | | | $ | 465,431 | | | $ | 655,540 | | | | | $ | (7,119) | | | $ | 676,391 | | | $ | 235 | | | $ | 676,626 | |
704,485 | |
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
7


SEMTECH CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
| | | | | | | | | | | | |
| | Three Months Ended |
| | October 31, 2021 | | October 25, 2020 |
| | May 1, 2022 | | May 2, 2021 |
| Cash flows from operating activities: | | | |
| Net income | $ | 90,854 | | | $ | 44,236 | |
| Net income | $ | 38,048 | | | $ | 23,498 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | | | |
| Depreciation and amortization | 7,668 | | | 7,420 | |
| Amortization of right-of-use assets | 1,140 | | | 1,055 | |
| | | | |
| Investment impairments and credit loss reserves | 24 | | | 246 | |
| Accretion of deferred financing costs and debt discount | 121 | | | 121 | |
| | | | |
| Deferred income taxes | (1,540) | | | (7,121) | |
| Deferred income taxes | 1,747 | | | (29) | |
| Share-based compensation | 10,893 | | | 11,839 | |
| Loss (gain) on disposition of assets | 8 | | | (20) | |
| Changes in the fair value of contingent earn-out obligations | - | | | (33) | |
| Equity in net gains of equity method investments | (24) | | | (78) | |
| | | | |
| | | | |
| Corporate-owned life insurance, net | (47) | | | 2,562 | |
| Changes in assets and liabilities: | | | |
| Accounts receivable, net | 5,147 | | | 3,915 | |
| Inventories | (17,665) | | | (5,357) | |
| Inventories | 712 | | | (6,425) | |
| Other assets | 8,130 | | | (15,109) | |
| Other assets | 3,017 | | | 5,815 | |
| Accounts payable | (3,325) | | | 157 | |
| Accounts payable | (126) | | | 1,513 | |
| Accrued liabilities | 15,816 | | | 1,992 | |
| Accrued liabilities | (16,808) | | | (14,659) | |
| | | | |
| Other liabilities | (6,787) | | | (604) | |
| Other liabilities | (1,469) | | | (4,188) | |
| Net cash provided by operating activities | 50,051 | | | 32,585 | |
| Cash flows from investing activities: | | | |
| | | | |
| Proceeds from sales of property, plant and equipment | - | | | 32 | |
| Purchase of property, plant and equipment | (8,315) | | | (5,760) | |
| Proceeds from sale of investments | - | | | 327 | |
| | | | |
| Purchase of investments | (5,832) | | | (10,938) | |
| Purchase of investments | (2,000) | | | (2,927) | |
| | | | |

| | | | |
| Proceeds from corporate-owned life insurance | 2,676 | | | - | |
| Premiums paid for corporate-owned life insurance | (2,676) | | | - | |
| | | | |
| Net cash used in investing activities | (10,315) | | | (8,655) | |
| Cash flows from financing activities: | | | |
| Proceeds from revolving line of credit | 10,000 | | | - | |
| Payments of revolving line of credit | - | | | (4,000) | |
| Deferred financing costs | - | | | (30) | |
| | | | |
| | | | |
| Payment for employee share-based compensation payroll taxes | (4,570) | | | (6,230) | |
| Proceeds from exercise of stock options | 417 | | | 628 | |
| Repurchase of common stock | (50,000) | | | (25,000) | |
| | | | |
| Net cash used in financing activities | (44,153) | | | (34,602) | |
| Net increase (decrease) in cash and cash equivalents | 7,708 | | | (31,053) | |
| Net decrease in cash and cash equivalents | (4,417) | | | (10,672) | |
| Cash and cash equivalents at beginning of period | 279,601 | | | 268,891 | |
| Cash and cash equivalents at end of period | $ | 275,184 | | | $ | 258,219 | |
| Supplemental disclosure of cash flow information: | | | |
| Interest paid | $ | 3,237 | | | $ | 4,976 | |
| Interest paid | $ | 987 | | | $ | 1,065 | |
| Income taxes paid | $ | 2,989 | | | $ | 8,086 | |
| Income taxes paid | $ | 3,347 | | | $ | 2,917 | |
| Non-cash investing and financing activities: | | | |
| Accounts payable related to capital expenditures | $ | 3,808 | | | $ | 2,355 | |
| Conversion of notes into equity | $ | - | | | $ | 626 | |
The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.
8


SEMTECH CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1: Organization and Basis of Presentation
Nature of Business
Semtech Corporation (together with its consolidated subsidiaries, the "Company" or "Semtech") is a leading global supplier of high performance analog and mixed-signal semiconductors and advanced algorithms. The end customers for the Company's products are primarily original equipment manufacturers that produce and sell electronics.
Fiscal Year
The Company reports results on the basis of 52 and 53-week periods and ends its fiscal year on the last Sunday in January. The other quarters generally end on the last Sunday of April, July and October, although the first and second quarters of fiscal year 2022 end on the first Sunday of May. and August, respectively.quarter of fiscal year 2023 ends on the first Sunday of May. All quarters consist of 13 weeks except for one 14-week period in the fourth quarter of 53-week years. The first quarters of fiscal years 2023 and 2022 each consisted of 13 weeks.
Principles of Consolidation
The accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company, in accordance with accounting principles generally accepted in the United States ("GAAP") and on the same basis as the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended January 30, 2022 ("Annual Report"). The Company's interim unaudited condensed consolidated statements of income are referred to herein as the "Statements of Income." The Company's interim unaudited condensed consolidated balance sheets are referred to herein as the "Balance Sheets" and interim unaudited condensed consolidated statements of cash flows as the "Statements of Cash Flows." In the opinion of the Company, these interim unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly, in all material respects, the financial position of the Company for the interim periods presented. All intercompany balances have been eliminated. Because the interim unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for a complete set of consolidated financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in the Company's Annual Report. The results reported in these interim unaudited condensed consolidated financial statements should not be regarded as indicative of results that may be expected for any subsequent period or for the entire year.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Recently Adopted Accounting Guidance
In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2019-12, "Simplifying the Accounting for Income Taxes," which modifies Accounting Standards Codification ("ASC") 740 to simplify the accounting for income taxes. This guidance impacts the accounting for hybrid tax regimes, the tax basis step-up in goodwill obtained in a transaction that is not a business combination, separate financial statements of legal entities not subject to tax, the intraperiod tax allocation exception to the incremental approach, ownership changes in investments from a subsidiary to an equity method investment and vice versa, interim period accounting for enacted changes in tax law and the year-to-date loss limitation in interim period tax Accounting This Guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within this those fiscal years, with early adoption permitted. The Company Adopted this guidance in the first quarter of fiscal year 2022Adoption of this guidance did not have a material impact on the Company's consolidated financial statements.
Held for Sale
As of May 1, 2022, the Company classified certain assets and liabilities as held for sale in the Balance Sheets. See Note 2, Divestiture, and Note 17, Subsequent Event, for additional information.
Accounting Guidance Issued, but not yet Adopted as of May 1, 2022

In October 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-08, "Business Combinations (Topic 805)-Accounting for Contract Assets and Contract Liabilities from Contracts with Customers," which improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistencies related to recognition of an acquired contract liability, and to payment terms and their effect on subsequent revenue recognized by the acquirer. Among other changes, this ASU requires that an acquirer account for acquired revenue contracts in accordance with Accounting Standards Codification ("ASC") 606, "Revenue from Contracts with Customers," as if it had originated the contracts. If the acquirer is unable to assess or rely on how the acquiree applied ASC 606, the acquirer should consider the terms of the acquired contracts as of the contract inception or contract modification date in applying ASC 606 to determine what should be recorded at the acquisition date. The amendments also provide certain practical expedients for acquirers when recognizing and measuring acquired contract assets and contract
liabilities from revenue contracts in a business combination. The guidance is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.
9


Note 2: Divestiture
The Company determined that its high reliability discrete diodes and assemblies business (the "Disposal Group") met the held for sale criteria as of May 1, 2022 and, as a result, related assets for this business were classified as "Assets held for sale" and related liabilities for this business were classified as "Liabilities held for sale" in the Balance Sheets as of May 1, 2022. The Company reclassified $0.8 million of goodwill to assets held for sale based on the relative fair value of the Disposal Group and the portion of the Wireless and Sensing reporting unit that will be retained. The estimated fair value of the Disposal Group less estimated costs to sell exceeded its carrying amount as of May 1, 2022. As the sale of the Disposal Group is not considered a strategic shift that will have a major effect on the Company's operations or financial results, it is not reported as discontinued operations.
The following table summarizes the Company's assets and liabilities held for sale by major class:
| | | | | | |
| | May 1, 2022 |
| (in thousands) | |
| Assets: | |
| Inventories | $ | 6,390 | |
| Property, plant and equipment, net | 1,182 | |
| Goodwill | 835 | |
| Other | 658 | |
| Total assets held for sale | $ | 9,065 | |
| | |
| Liabilities: | |
| Accounts payable | $ | 483 | |
| Accrued liabilities | 759 | |
| Total liabilities held for sale | $ | 1,242 | |
On May 3, 2022, the Company completed the divestiture of the Disposal Group. See Note 17, Subsequent Event, for additional information.

10


Note 3: Earnings per Share
The computation of basic and diluted earnings per share was as follows:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands, except per share data) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |May 1, 2022 | | May 2, 2021 | | | | |
| Net income attributable to common stockholders | $ | 34,427 | | | $ | 18,487 | | | $ | 90,860 | | | $ | 44,247 | |38,049 | | | $ | 23,500 | | | | | |
| | | | | | | | |
| Weighted-average shares outstanding-basic | 64,546 | | | 65,136 | | | 64,786 | | | 65,270 | |63,950 | | | 65,089 | | | | | |
| Dilutive effect of share-based compensation | 753 | | | 831 | | | 878 | | | 780 | |603 | | | 1,021 | | | | | |
| Weighted-average shares outstanding-diluted | 65,299 | | | 65,967 | | | 65,664 | | | 66,050 | |64,553 | | | 66,110 | | | | | |
| | | | | | | | |
| Earnings per share: | | | | | | | |
| Basic | $ | 0.53 | | | $ | 0.28 | | | $ | 1.40 | | | $ | 0.68 | |
| Basic | $ | 0.59 | | | $ | 0.36 | | | | | |
| Diluted | $ | 0.59 | | | | $ | 0.36 | | | | | |
| | | | | | | | |
| Anti-dilutive shares not included in the above calculations | 64 | | | - | | | | | |
Diluted earnings per share incorporates the incremental shares issuable, calculated using the treasury stock method, upon the assumed exercise of non-qualified stock options and the vesting of restricted stock units and market-condition restricted stock unit awards if certain conditions have been met, but excludes such incremental shares that would have an anti-dilutive effect.
11


Note 4: Share-Based Compensation
Financial Statement Effects and Presentation
Pre-tax share-based compensation was included in the Statements of Income as follows:
| | | | | | | | | | | | | | | | || | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 | | | | |
| Cost of sales | $ | 743 | | | $ | 654 | | | $ | 2,112 | | | $ | 1,734 | |
| Cost of sales | $ | 775 | | | $ | 718 | | | | | |
| Selling, general and administrative | 12,528 | | | 9,404 | | | 26,985 | | | 24,864 | |6,132 | | | 7,359 | | | | | |
| Product development and engineering | 4,070 | | | 3,480 | | | 11,600 | | |9,505 | |3,986 | | | 3,762 | | | | | |
| Total share-based compensation | $ | 17,341 | | | $ | 13,538 | | | $ | 40,697 | | | $ | 36,103 | |10,893 | | | $ | 11,839 | | | | | |
| | | | | | | | |
Restricted Stock Units, Employees
The Company grants restricted stock units to certain employees, which are expected to be settled with shares of the Company's common stock. The grant date for these awards is equal to the measurement date. These awards are valued as of the measurement date, based on the fair value of the Company's common stock at the grant date, and recognized as share-based compensation expense over the requisite vesting period (typically 4 years). In the nine months ended October 31, 2021, the Company granted 731,563 three months ended May 1, 2022, the Company granted 166,023 restricted stock units to employees.
Restricted Stock Units, Non-Employee Directors
The Company maintains a compensation program pursuant to which restricted stock units are granted to the Company's directors that are not employed by the Company or any of its subsidiaries. Under the Company's director compensation program, a portion of the restricted stock units granted under the program will be settled in cash and a portion will be settled in shares of the Company's common stock. Restricted stock units awarded under the program are scheduled to vest on the earlier of (i) one year after the grant date or (ii) the day immediately preceding the Company's annual meeting of stockholders in the year following the grant. The portion of a restricted stock unit award under the program that is to be settled in cash will, subject to vesting, be settled when the director who received the award separates from the board of directors. The portion of a restricted stock unit award under the program that is to be settled in shares of the Company's common stock will, subject to vesting, be settled promptly following vesting. In the nine months ended October 31, 2021, the Company granted to the non-employee directors 11,898 restricted stock units that settle in cash and 11,898 restricted stock units that settle in shares.
Total Stockholder Return ("TSR") Market-Condition Restricted Stock Units
The Company grants TSR market-condition restricted stock units (the "TSR Awards") to certain executives of the Company. The TSR Awards have a pre-defined market-condition, which determines the number of shares that ultimately vest, as well as a service condition. The TSR Awards are valued as of the grant date using a Monte Carlo simulation, which takes into consideration the possible outcomes pertaining to the TSR market condition and expense is recognized on a straight-line basis over the requisite service periods and is adjusted for any actual forfeitures.
In the nine months ended October 31, 2021, the Company granted 81,688 In the three months ended May 1, 2022, the Company granted 125,399 TSR Awards, which are accounted for as equity awards. The market condition is determined based upon the Company's TSR benchmarked against the TSR of the S&P SPDR Semiconductor ETF (NYSE:XSD) over one, two and three year periods (one-third of the awards vesting each performance period). Generally, the fiscal year 2023 TSR Award recipients must be employed for the entire performance period and be an active employee at the time of vesting of the awards. The grant-date fair value per unit of the TSR Awards granted in the three months ended May 1, 2022 for each one, two and three year performance period was $57.92, $68.94 and $75.69, respectively.

Market-Condition Restricted Stock Units
In the nine months ended October 31, 2021, the Company granted an additional 54,928 restricted stock units with a different market condition. These additional awards are eligible to vest during the period commencing March 9, 2021, and ending March 5, 2024 (the "Performance Period") as follows: the restricted stock units covered by the award will vest if, during any consecutive 30 trading day period that commences and ends during the Performance Period, the average per-share closing price of the Company's common stock equals or exceeds $95.00. The grant-date fair value per unit of the awards granted in the nine months ended October 31, 2021 was $49.55.


12


Note 5: Available-for-sale securities
The following table summarizes the values of the Company's available-for-sale securities:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | October 31, 2021 | | January 31, 2021 |
| | May 1, 2022 | | January 30, 2022 |
| (in thousands) | Fair Value | | Amortized | | Gross | | Fair Value | | Amortized | | Gross |
| | | | Cost | | Unrealized Gain/(Loss) | | | | Cost | | Unrealized Gain/(Loss) |
| Convertible debt | $ | 11,677 | | | $ | 13,862 | | | $ | (2,185) | | | $ | 11,989 | | | $ | 13,244 | | | $ | (1,255) | |
| Convertible debt | $ | 13,130 | | | $ | 14,683 | | | $ | (1,553) | | | $ | 12,872 | | | $ | 14,401 | | | $ | (1,529) | |
| Total available-for-sale securities | $ | 11,677 | | | $ | 13,862 | | | $ | (2,185) | | | $ | 11,989 | | | $ | 13,244 | | | $ | (1,255) | |13,130 | | | $ | 14,683 | | | $ | (1,553) | | | $ | 12,872 | | | $ | 14,401 | | | $ | (1,529) | |
The following table summarizes the maturities of the Company's available-for-sale securities:
| | | | | | | | | | | | | | | | |
| | May 1, 2022 | | |
| (in thousands) | Fair Value | | Amortized Cost | | | | |
| Within 1 year | $ | 10,466 | | | $ | 11,960 | | | | | |
| Within 1 year | $ | 11,544 | | | $ | 12,366 | | | | | |
| After 1 year through 5 years | 1,586 | | | 2,317 | | | | | |
| Total available-for-sale securities | $ | 13,130 | | | $ | 14,683 | | | | | |
The Company's available-for-sale securities consist of investments in convertible debt instruments issued by privately-held companies. The available-for-sale securities with maturities within one year were included in "Other current assets" and maturities greater than one year were included in "Other assets" in the Balance Sheets.






13


Note 6: Fair Value Measurements
The following fair value hierarchy is applied for disclosure of the inputs used to measure fair value and prioritizes the inputs into three levels as follows:
Level 1-Quoted prices in active markets for identical assets or liabilities.
Level 2-Observable inputs other than Level 1 prices, such as quoted prices for similar assets and liabilities in active markets or other inputs that are observable for the assets or liabilities, either directly or indirectly.
Level 3-Unobservable inputs based on the Company's own assumptions, requiring significant management judgment or estimation.
Instruments Measured at Fair Value on a Recurring Basis
The fair values of financial assets and liabilities measured and recorded at fair value on a recurring basis were presented in the Balance Sheets as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | October 31, 2021 | | January 31, 2021 |
| | May 1, 2022 | | January 30, 2022 |
| (in thousands) | Total | | (Level 1) | | (Level 2) | | (Level 3) | | Total | | (Level 1) | | (Level 2) | | (Level 3) |
| Financial assets: | | | | | | | | | | | | | | | |
| Interest rate swap agreement | $ | 1,983 | | | $ | - | | | $ | 1,983 | | | $ | - | | | $ | 229 | | | $ | - | | | $ | 229 | | | $ | - | |
| | | | | - | | | 175 | | | - | | | | | |
| Convertible debt | 13,130 | | | - | | | - | | | 11,677 | | | 11,989 | | | - | | | - | | | 11,989 | |13,130 | | | 12,872 | | | - | | | - | | | 12,872 | |
| | | | | | | | | | | | | | | | |
| Total financial assets | $ | 15,113 | | | $ | - | | | $ | 1,983 | | | $ | 13,130 | | | $ | 13,101 | | | $ | - | | | $ | 229 | | | $ | 12,872 | |
| | | | | | | | | | | | | | | | |
| Financial liabilities: | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| Interest rate swap agreement | $ | 654 | | | $ | - | | | $ | 654 | | | $ | - || | $ | 1,782 | | | | | | | | | | | | | | | | |
| Total return swap contracts | $ | 317
| | | $ | - | | | $ | 317 | | | $ | - | |
| Total return swap contracts | - | | | - | | | -| $ | 257 | | | $ | - | | | $ | 257 | | | $ | - | |
| Total financial liabilities | $ | 317 | | | $ | - | | | $ | 317 | | | $ | - | | | $ | 257 | | | $ | - | | | $ | 257 | | | $ | - | |
During the nine months ended October 31, 2021, During the three months ended May 1, 2022, the Company had no transfers of financial assets or liabilities between Level 1, Level 2 or Level 3. As of May 1, 2022 and January 30, 2022, the Company had not elected the fair value option for any financial assets and liabilities for which such an election would have been permitted.
The convertible debt investments are valued utilizing a combination of estimates that are based on the estimated discounted cash flows associated with the debt and the fair value of the equity into which the debt may be converted, all of which are Level 3 inputs.
The following table presents a reconciliation of the changes in the convertible debt investments in the three months ended May 1, 2022:
| | | | | | | | | |
| (in thousands) | | |
| Balance at January 31, 2021 | | $ | 11,989 | |
| Balance at January 30, 2022 | | $ | 12,872 | |
| | | |
| | | |
| Increase in credit loss reserve | | (24) | |
| Interest accrued | | 282 | |
| | | |
| Balance at October 31, 2021 | | $ | 11,677 | |
| Balance at May 1, 2022 | | $ | 13,130 | |
The interest rate swap agreement is measured at fair value using readily available interest rate curves (Level 2 inputs). The fair value of the agreement is determined by comparing, for each settlement, the contract rate to the forward rate and discounting to the present value. Contracts in a gain position are recorded in "Other current assets" and "Other assets" in the Balance Sheets and the value of contracts in a loss position are recorded in "Accrued liabilities" and "Other long term liabilities" in the Balance Sheets. See Note 16, Derivatives and Hedging Activities, for further discussion of the Company's derivative instruments.
The total return swap contracts are measured at fair value using quoted prices of the underlying investments (Level 2 inputs). The fair values of the total return swap contracts are recognized in the Balance Sheets in "Accrued Liabilities" if the instruments are in a loss position and in "Other Current Assets" if the instruments are in a gain position. See Note 16, Derivatives and Hedging Activities, for further discussion of the Company's derivative instruments.
14
Instruments Not Recorded at Fair Value on a Recurring Basis
Some of the Company's financial instruments are not measured at fair value on a recurring basis, but are recorded at amounts that approximate fair value due to their liquid or short-term nature. Such financial assets and financial liabilities include: cash and cash equivalents including money market deposits, net receivables, certain other assets, accounts payable, accrued
14


expenses, accrued personnel costs, and other current liabilities. The Company's long-term debt is recorded at cost, which approximates fair value as the long-term debt bears interest at a floating rate.
Assets and Liabilities Recorded at Fair Value on a Non-Recurring Basis
The Company reduces the carrying amounts of its goodwill, intangible assets, long-lived assets and non-marketable equity securities to fair value when held for sale or determined to be impaired.
Investment Impairments and Credit Loss Reserves
The total credit loss reserve for the Company's held-to-maturity debt securities and available-for-sale debt securities was $4.3 million and $3.4 million as of October 31, 2021 and January 31, 2021, respectively. During the three and nine months ended October 31, $4.5 million as of May 1, 2022 and January 30, 2022. During the three months ended May 2, 2021, the Company increased its expected credit loss reserves by $0.2 million and $0.9 million, respectively, for its available-for-sale debt securities. and did not record any impairments on its non-marketable equity investments. Upon the adoption of ASU 2016-13 in the first quarter of fiscal year 2021, the Company recorded expected Credit loss reserves of $0.4 million related to its held-to-maturity debt securities During the three and nine months ended October 25, 2020, the Company increased its expected credit loss reserves by $0.3 million and $2.7 million, respectively, for its Credit loss reserves related to the Company's available-for-sale debt securities and held-to-maturity debt securities with maturities within one year were included in "Other current assets" and with maturities greater than one year were included in "Other assets" in the Balance Sheets. and available-for-sale debt securities in-part, due to the impact of the COVID-19 pandemic on early-stage development companies. Additionally, during the three and nine months ended October 25, 2020, the Company recorded zero and $2.9 million, respectively, of impairments on its non-marketable equity investments.





15


Note 7: Inventories
Inventories, consisting of material, material overhead, labor, and manufacturing overhead, are stated at the lower of cost (first-in, first-out) or net realizable value and consisted of the following:
| | | | | | | | | | | | |
| (in thousands) | October 31, 2021 | | January 31, 2021 |
| (in thousands) | May 1, 2022 | | January 30, 2022 |
| Raw materials | $ | 4,357 | | | $ | 2,936 | |
| Raw materials | $ | 2,616 | | | $ | 4,304 | |
| Work in progress | 72,551 | | | 59,523 | |
| Work in progress | 77,021 | | | 85,445 | |
| Finished goods | 28,251 | | | 25,035 | |
| Finished goods | 27,264 | | | 24,254 | |
| Total inventories | $ | 106,901 | | | $ | 114,003 | |
As of May 1, 2022, inventories excluded amounts classified as held for sale. See Note 2, Divestiture, for additional information.

16


Note 8: Goodwill and Intangible Assets
Goodwill
The carrying amounts of goodwill by applicable reporting unit were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | |
| (in thousands) | Signal Integrity | | Wireless and Sensing | | Protection | | Total |
| Balance at January 30, 2022 | $ | 274,085 | | | $ | 72,128 | | | $ | 4,928 | | | $ | 351,141 | |
| Reclassifications to assets held for sale | - | | | (835) | | | - | | | (835) | |
| Balance at May 1, 2022 | $ | 274,085 | | | $ | 71,293 | | | $ | 4,928 | | | $ | 350,306 | |
Goodwill is not amortized, but is tested for impairment at the reporting unit level using either a qualitative or quantitative assessment on an annual basis during the fourth quarter of each fiscal year, and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Impairment of goodwill is measured at the reporting unit level by comparing the reporting unit's carrying amount, including goodwill, to the fair market value of the reporting unit. As of May 1, 2022, there was no indication of impairment of the Company's goodwill balances and goodwill excluded amounts reclassified to assets held for sale. See Note 2, Divestiture, for additional information.
Purchased Intangibles
The following table sets forth the Company's finite-lived intangible assets resulting from business acquisitions and technology licenses purchased, which are amortized over their estimated useful lives:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | October 31, 2021 | | January 31, 2021 |
| | | | May 1, 2022 | | January 30, 2022 |
| (in thousands, except estimated useful life) | Estimated | | Gross | | Accumulated | | Net Carrying | | Gross | | Accumulated | | Net Carrying |
| | Useful Life | | Carrying | | Amortization | | Amount | | Carrying | | Amortization | | Amount |
| | | | Amount | | | | | | Amount | | | | |
| Core technologies | 6-8 years | | $ | 26,300 | | | $ | (18,448) | | | $ | 7,852 | | | $ | 29,300 | | | $ | (17,554) | | | $ | 11,746 | |(20,544) | | | $ | 5,756 | | | $ | 26,300 | | | $ | (19,496) | | | $ | 6,804 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| Total finite-lived intangible assets | | | $ | 26,300 | | | $ | (18,448) | | | $ | 7,852 | | | $ | 29,300 | | | $ | (17,554) | | | $ | 11,746 | |(20,544) | | | $ | 5,756 | | | $ | 26,300 | | | $ | (19,496) | | | $ | 6,804 | |
Amortization expense of finite-lived intangible assets recorded in the Statements of Income for each period was as follows:
| | | | | | | | | | | | | | | | || | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 | | | | |
| Core technologies | $ | 1,298 | | | $ | 1,798 | | | $ | 3,894 | | | $ | 6,069 | |
| Core technologies | $ | 1,048 | | | $ | 1,298 | | | | | |
| | | | | - | | | - | | | 589 | |
| Total amortization expense | $ | 1,298 | | | $ | 1,798 | | | $ | 3,894 | | | $ | 6,658 | |1,048 | | | $ | 1,298 | | | | | |
Future amortization expense of finite-lived intangible assets is expected as follows:
| | | | | | | | | | |
| (in thousands) | | | | | |
| Fiscal Year Ending: | | | | | |
| 2022 (remaining three months) | $ | 1,048 | | | | | |
| 2023 (remaining nine months) | $ | 2,954 | | | | | |
| 2023 | 4,002 | | | | | |
| 2024 | 1,676 | | | | | |
| 2025 | 288 | | | | | |
| 2026 | 288 | | | | | |
| 2027 | 288 | | | | | |
| Thereafter | 262 | | | | | |
| Total expected amortization expense | $ | 5,756 | | | | | |

17


Note 9: Long-Term Debt
Long-term debt and the current period interest rates were as follows:
| | | | | | | | | | | | |
| | |
| (in thousands, except percentages) | May 1, 2022 | | January 30, 2022 |
| Revolving loans | $ | 177,000 | | | $ | 181,000 | |
| Revolving loans | $ | 183,000 | | | $ | 173,000 | |
| | | | |
| | | | |
| | | | |
| Debt issuance costs | (1,444) | | | (1,805) | |
| Debt issuance costs | (1,203) | | | (1,324) | |
| Total long-term debt, net of debt issuance costs | $ | 181,797 | | | $ | 171,676 | |
| Effective interest rate (1) | 1.93 | % | | 1.90 | % |
(1) The revolving loans bear interest at a variable rate based on LIBOR or a Base Rate, at the Company's option, plus an applicable margin that varies based on the Company's consolidated leverage ratio. In the first quarter of fiscal year 2021, the Company entered into a three-year interest rate swap agreement that fixed the interest on the first $150.0 million of debt outstanding under the revolving loans at 1.9775%. As of May 1, 2022, the effective interest rate was a weighted-average rate that represented (a) interest on the first $150.0 million of the debt outstanding at a fixed LIBOR rate of 0.7275% plus a margin of 1.25% (total fixed rate of 1.9775%), and (b) interest on the remainder of the debt outstanding at a variable rate based on the one-month LIBOR rate, which was 0.49% as of May 1, 2022, plus a margin of 1.25% (total variable rate of 1.74%). As of January 30, 2022, the effective interest rate was a weighted-average rate that represented (a) interest on the first $150.0 million of the debt outstanding at a fixed LIBOR rate of 0.7275% plus a margin of 1.25% (total fixed rate of 1.9775%), and (b) interest on the remainder of the debt outstanding at a variable rate based on the one-month LIBOR rate, which was 0.11% as of January 30, 2022, plus a margin of 1.25% (total variable rate of 1.36%).
On November 7, 2019, the Company, with certain of its domestic subsidiaries as guarantors, entered into an amended and restated credit agreement with the lenders party thereto and HSBC Bank USA, National Association, as administrative agent, swing line lender and letter of credit issuer. The borrowing capacity of the revolving loans under the senior secured first lien credit facility (the "Credit Facility") is $600.0 million and matures on November 7, 2024. As of May 1, 2022, the Company had $183.0 million outstanding under its Credit Facility and $417.0 million of undrawn borrowing capacity, and the Company was in compliance with the covenants required under the Credit Facility.
On August 11, 2021, the Company entered into an amendment to the Credit Agreement in order to, among other things, (i) provide for contractual fallback language for LIBOR replacement to reflect the Alternative Reference Rates Committee hardwired approach and (ii) incorporate certain provisions that clarify the rights of the administrative agent to recover from lenders or other secured parties erroneous payments made to such lenders or secured parties.
Interest expense was comprised of the following components for the periods presented:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 | | | | |
| Contractual interest (1) | $ | 1,113 | | | $ | 888 | | | $ | 3,256 | | |$ | 3,457 | |1,076 | | | $ | 1,078 | | | | | |
| Amortization of debt discount and issuance costs | 120 | | | 120 | | | 361 | | |362 | |121 | | | 121 | | | | | |
| Total interest expense | $ | 1,233 | | | $ | 1,008 | | | $ | 3,617 | | | $ | 3,819 | |
| Total interest expense | $ | 1,197 | | | $ | 1,199 | | | | | |
(1) Contractual interest represents the interest on the Company's outstanding debt after giving effect to the interest rate swap agreement.
As of May 1, 2022, there were no amounts outstanding under the letters of credit, swing line loans and alternative currency sub-facilities.
18


Note 10: Income Taxes
The Company's effective tax rate differs from the statutory federal income tax rate of 21% primarily due to the regional mix of income, withholding taxes on certain foreign earnings, excess tax benefits from share-based compensation and research and development tax credits. impact of global intangible low-taxed income ("GILTI") and research and development ("R&D") tax credits. The Tax Cuts and Jobs Act requires R&D costs incurred for tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years for tax purposes, depending on where the research activities are conducted. The Company has elected to treat GILTI as a period cost and the additional capitalization of R&D costs within GILTI increases the Company's provision for income taxes.
The Company uses a two-step approach to recognize and measure uncertain tax positions ("UTP"). The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained in audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement.
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits (before the federal impact of state items) is as follows:
| | | | | | |
| (in thousands) | |
| Balance at January 31, 2021 | $ | 26,850 | |
| Balance at January 30, 2022 | $ | 27,051 | |
| Additions/(decreases) based on tax positions related to the current fiscal year | 181 | |
| Additions/(decreases) based on tax positions related to the prior fiscal years | (34) | |
| | |
| Balance at October 31, 2021 | $ | 26,376 | |
| Balance at May 1, 2022 | $ | 27,198 | |
Included in the balance of gross unrecognized tax benefits at October 31, 2021 and January 31, 2021 are $8.8 million and $9.7 May 1, 2022 and January 30, 2022 are $9.4 million and $9.3 million, respectively, of net tax benefits (after the federal impact of state items), that, if recognized, would impact the effective tax rate, prior to consideration of any required valuation allowance.
The liability for UTP is reflected in the Balance Sheets as follows:
| | | | | | | | | | | | |
| (in thousands) | October 31, 2021 | | January 31, 2021 |
| (in thousands) | May 1, 2022 | | January 30, 2022 |
| Deferred tax assets - non-current | $ | 16,440 | | | $ | 16,346 | |
| Other long-term liabilities | 9,384 | | | 9,335 | |
| Total accrued taxes | $ | 25,010 | | | $ | 25,501 | |
| Total accrued taxes | $ | 25,824 | | | $ | 25,681 | |
The Company's policy is to include net interest and penalties related to unrecognized tax benefits in the "Provision for income taxes" in the Statements of Income.
Tax years prior to 2013 (the Company's fiscal year 2014) are generally not subject to examination by the United States ("U.S.") Internal Revenue Service except for items involving tax attributes that have been carried forward to tax years whose statute of limitations remains open. For state returns in the U.S., the Company is generally not subject to income tax examinations for calendar years prior to 2012 (the Company's fiscal year 2013). The Company has a significant tax presence in Switzerland for which Swiss tax filings have been examined through fiscal year 2020. The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. The Company believes that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax examinations cannot be predicted with certainty. If any issues addressed in the Company's tax examinations are resolved in a manner not consistent with the Company's expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.
The Company's regional income (loss) from continuing operations before taxes and equity in net gains of equity method investments was as follows:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 | | | | |
| Domestic | $ | (5,358) | | | $ | (2,054) | | | $ | (17,466) | | |$ | (19,065) | |
| Domestic | $ | (4,782) | | | $ | (5,484) | | | | | |
| Foreign | 41,438 | | | 21,957 | | | 115,384 | | |65,813 | |
| Foreign | 50,875 | | | 32,102 | | | | | |
| Total | $ | 36,080 | | | $ | 19,903 | | | $ | 97,918 | | | $ | 46,748 | |
| Total | $ | 46,093 | | | $ | 26,618 | | | | | |
19


Note 11: Leases
The Company has operating leases for real estate, vehicles, and office equipment, which are accounted for in accordance with ASC 842, "Leases." Real estate leases are used to secure office space for the Company's administrative, engineering, production support and manufacturing activities. The Company's leases have remaining lease terms of up to approximately ten years, some of which include options to extend the leases for up to five years, and some of which include options to terminate the leases within one year.
The components of lease expense were as follows:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 | | | | |
| Operating lease cost | $ | 1,441 | | | $ | 1,178 | | | $ | 4,265 | | | $ | 3,533 | |
| Operating lease cost | $ | 1,446 | | | $ | 1,337 | | | | | |
| Short-term lease cost | 302 | | | - | | | 805 | | |- | |
| Short-term lease cost | 271 | | | 244 | | | | | |
| Sublease income | (32) | | | (35) | | | (107) | | | (102) | |
| Sublease income | (35) | | | (20) | | | | | |
| Total lease cost | $ | 1,711 | | | $ | 1,143 | | | $ | 4,963 | | | $ | 3,431 | |
| Total lease cost | $ | 1,682 | | | $ | 1,561 | | | | | |
Supplemental cash flow information related to leases was as follows:
| | | | | | | | | | | | |
| | Three Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 |
| Cash paid for amounts included in the measurement of lease liabilities | $ | 1,709 | | | $ | 1,731 | |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $ | 465 | | | $ | 33 | |
| | | | |
| | | | | | |
| | |
| | May 1, 2022 |
| Weighted-average remaining lease term-operating leases (in years) | 5.41 |
| Weighted-average discount rate on remaining lease payments-operating leases | 6.3 | % |
| | |
| | |
Supplemental balance sheet information related to leases was as follows:
| | | | | | | | | | | | |
| | |
| (in thousands) | October 31, 2021 | | January 31, 2021 |
| (in thousands) | May 1, 2022 | | January 30, 2022 |
| Operating lease right-of-use assets in "Other assets" | $ | 19,102 | | | $ | 19,777 | |
| | | | |
| Operating lease liabilities in "Accrued liabilities" | $ | 3,790 | | | $ | 3,977 | |
| Operating lease liabilities in "Other long-term liabilities" | 15,446 | | | 16,577 | |
| Total operating lease liabilities | $ | 19,236 | | | $ | 20,554 | |
Maturities of lease liabilities as of May 1, 2022 are as follows:
| | | | | | |
| (in thousands) | |
| Fiscal Year Ending: | |
| 2022 (remaining three months) | $ | 1,357 | |
| 2023 (remaining nine months) | $ | 3,644 | |
| 2024 | 4,567 | |
| 2025 | 4,414 | |
| 2026 | 3,391 | |
| 2027 | 2,206 | |
| Thereafter | 4,544 | |
| Total lease payments | 22,766 | |
| Less: imputed interest | (3,530) | |
| Total | $ | 19,236 | |

20


Note 12: Commitments and Contingencies
In accordance with ASC 450-20, "Loss Contingencies," the Company accrues an undiscounted liability for those contingencies where the incurrence of a loss is probable and the amount can be reasonably estimated. The Company also discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its consolidated financial statements not to be misleading. material. The Company does not record liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated, or when the liability is believed to be only reasonably possible or remote. The Company evaluates, at least quarterly, developments in its legal matters that could affect the amount of liability that has been previously accrued, and makes adjustments as appropriate. Significant judgment is required to determine both probability and the estimated amount. The Company may be unable to estimate a possible loss or range of possible loss due to various reasons, including, among others: (i) if the damages sought are indeterminate, (ii) if the proceedings are in early stages, (iii) if there is uncertainty as to the outcome of pending appeals, motions or settlements, (iv) if there are significant factual issues to be determined or resolved, and (v) if there are novel or unsettled legal theories presented. In such instances, there is considerable uncertainty regarding the ultimate resolution of such matters, including a possible eventual loss, if any.
Because the outcomes of litigation and other legal matters are inherently unpredictable, the Company's evaluation of legal matters or proceedings often involves a series of complex assessments by management about future events and can rely heavily on estimates and assumptions. While the consequences of certain unresolved matters and proceedings are not presently determinable, and an estimate of the probable and reasonably possible loss or range of loss in excess of amounts accrued for such proceedings cannot be reasonably made, an adverse outcome from such proceedings could have a material adverse effect on the Company's earnings in any given reporting period. However, in the opinion of management, after consulting with legal counsel, any ultimate liability related to current outstanding claims and lawsuits, individually or in the aggregate, is not expected to have a material adverse effect on the Company's consolidated financial statements, as a whole. However, legal matters are inherently unpredictable and subject to significant uncertainties, some of which are beyond the Company's control.
As such, even though the Company intends to vigorously defend itself with respect to its legal matters, there can be no assurance that the final outcome of these matters will not materially and adversely affect the Company's business, financial condition, operating results, or cash flows.
From time to time, the Company is involved in various claims, litigation, and other legal actions that are normal to the nature of its business, including with respect to intellectual property, contract, product liability, employment, and environmental matters. In the opinion of management, after consulting with legal counsel, any ultimate liability related to current outstanding claims and lawsuits, individually or in the aggregate, is not expected to have a material adverse effect on the Company's consolidated financial statements, as a whole.
Environmental Matters
The Company vacated a former facility in Newbury Park, California in 2002, but continues to address groundwater and soil contamination at the site. The Company's efforts to address site conditions have been at the direction of the Los Angeles Regional Water Quality Control Board ("RWQCB"). In October 2013, an order was issued including a scope of proposed additional site work, monitoring, and remediation activities. The Company has been complying with RWQCB orders and direction, and continues to implement an approved remedial action plan addressing the soil, groundwater, and soil vapor at the site.
The Company has accrued liabilities where it is probable that a loss will be incurred and the cost or amount of loss can be reasonably estimated. Based on the latest determinations by the RWQCB and the most recent actions taken pursuant to the remedial action plan, the Company estimates the range of probable loss between $7.9 million and $9.4 million. To date, the Company has made $5.8 million in payments towards the remedial action plan and, as of May 1, 2022, has a remaining accrual of $2.1 million related to this matter. Given the uncertainties associated with environmental assessment and the remediation activities, the Company is unable to determine a best estimate within the range of loss. Therefore, the Company has recorded the minimum amount of probable loss. These estimates could change as a result of changes in planned remedial actions, further actions from the regulatory agency, remediation technology, and other factors.
Indemnification
The Company has entered into agreements with its current and former executives and directors indemnifying them against certain liabilities incurred in connection with the performance of their duties. The Company's Certificate of Incorporation and Bylaws also contain indemnification obligations with respect to the Company's current directors and employees.
Product Warranties
The Company's general warranty policy provides for repair or replacement of defective parts. In some cases, a refund of the purchase price is offered. In certain instances, the Company has agreed to other or additional warranty terms, including indemnification provisions.
The product warranty accrual reflects the Company's best estimate of probable liability under its product warranties. The Company accrues for known warranty issues if a loss is probable and can be reasonably estimated, and accrues for estimated incurred but unidentified issues based on historical experience. Historically, warranty expense and the related accrual has been immaterial to the Company's consolidated financial statements.
Deferred Compensation
The Company maintains a deferred compensation plan for certain officers and key executives that allows participants to defer a portion of their compensation for future distribution at various times permitted by the plan. This plan provides for a discretionary Company match up to a defined portion of the employee's deferral, with any match subject to a defined vesting schedule.
The Company's liability for the deferred compensation plan is presented below:
| | | | | | | | | | | | |
| (in thousands) | October 31, 2021 | | January 31, 2021 |
| (in thousands) | May 1, 2022 | | January 30, 2022 |
| Accrued liabilities | $ | 2,333 | | | $ | 1,709 | |
| Accrued liabilities | $ | 1,821 | | | $ | 1,966 | |
| Other long-term liabilities | 41,305 | | | 43,197 | |
| Total deferred compensation liabilities under this plan | $ | 43,126 | | | $ | 45,163 | |
The Company has purchased whole life insurance on the lives of certain current deferred compensation plan participants. This corporate-owned life insurance is held in a grantor trust and is intended to cover a majority of the Company's costs of the deferred compensation plan. The cash surrender value of the corporate-owned life insurance was $37.9 million and $27.6 million as of October 31, 2021 and January 31, 2021, $33.7 million and $35.2 million as of May 1, 2022 and January 30, 2022, respectively, and is included in "Other assets" in the Balance Sheets. The decrease in the cash surrender value of the corporate-owned life insurance as of October 31, 2021 compared to January 31, 2021 was related to the overall increase in market value and $6.0 million of premiums paid May 1, 2022 compared to January 30, 2022 was primarily related to a $2.6 million decrease in market value and a $1.6 million reduction in cash surrender value related to a death benefit, partially offset by the re-investment of $2.7 million of proceeds from the death benefit into the corporate-owned life insurance policy in order to provide substantive coverage for the Company's deferred compensation liability.
Earn-out Liability
Pursuant to the terms of an amended arrangement with the former shareholders of Cycleo SAS, which the Company acquired in March 2012, earn-out payments are based on the achievement of a combination of certain sales and operating income milestones over the period of April 27, 2015 to April 26, 2020. No payments have been made during fiscal years 2022 and 2021 for the remaining earn-out milestone pending the outcome or resolution of a dispute between the Company and the earn-out participants. Any payment that may be made for the remaining portion of the earn-out is not expected to be material.

21


Note 13: Concentration of Risk
The following significant customers accounted for at least 10% of the Company's net sales in one or more of the periods indicated:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (percentage of net sales) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (percentage of net sales) | May 1, 2022 | | May 2, 2021 | | | | |
| Trend-tek Technology Ltd. (and affiliates) | 18 | % | | 16 | % | | | | |
| Frontek Technology Corporation (and affiliates) | 15 | % | | 19 | % | | | | |
| Arrow Electronics (and affiliates) | 11 | % | | 9 | % | | 11 | % | | 9 | % |
| | | | | | | | |
| CEAC International Limited | 13 | % | | 10 | % | | 10 | % | | 11 | % |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
The following table shows the customers that had an outstanding receivable balance that represented at least 10% of the Company's total net receivables as of one or more of the dates indicated:
| | | | | | | | | | | | |
| | |
| (percentage of net receivables) | May 1, 2022 | | January 30, 2022 |
| Frontek Technology Corporation (and affiliates) | 15 | % | | 17 | % |
| Arrow Electronics (and affiliates) | 13 | % | |9 | % |
| | | | |
| Trend-tek Technology Ltd (and affiliates) | 11 | % | | 7 | % |
| CEAC International Limited | 11 | % | | 10 | % |
Outside Subcontractors and Suppliers
The Company relies on a limited number of third-party subcontractors and suppliers for the production of silicon wafers, packaging and certain other tasks. Disruption or termination of supply sources or subcontractors, including due to the COVID-19 pandemic or natural disasters such as an earthquake or other causes, have delayed and could in the future delay shipments and could have a material adverse effect on the Company. Although there are generally alternate sources for these materials and services, qualification of the alternate sources could cause delays sufficient to have a material adverse effect on the Company. A significant amount of the Company's third-party subcontractors and suppliers, including third-party foundries that supply silicon wafers, are located in the U.S., Taiwan and China. A significant amount of the Company's assembly and test operations are conducted by third-party contractors in China, Taiwan and Malaysia.

22


Note 14: Segment Information
The Company's Chief Executive Officer functions as the chief operating decision maker ("CODM"). The CODM makes operating decisions and assesses performance based on the Company's major product lines, which represent its operating segments. The Company has three operating segments-Signal Integrity, Wireless and Sensing and Protection-that historically have been aggregated into one reportable segment identified as the "Semiconductor Products Group." In the fourth quarter of fiscal year 2022, the Company updated its forecasts and assessed the economic performance of the three operating segments and concluded that Protection is no longer expected to be economically similar to the other operating segments. This is primarily because the Company's projections indicate that the gross margin of products within Protection will not be economically similar to products within the other operating segments. Accordingly, the Company concluded that Protection should be separately reported as its own reportable segment. This decision resulted in the formation of two reportable segments, including the High-Performance Analog Group, which is comprised of the Signal Integrity and Wireless and Sensing operating segments, and the System Protection Group, which is comprised of the Protection operating segment. All prior year information in the tables below has been revised retrospectively to reflect the change to the Company's reportable segments.
The Company's assets are commingled among the three operating segments and the CODM does not use asset information in making operating decisions or assessing performance. Therefore, the Company has not included asset information by reportable segment in the segment disclosures below.
Net sales and gross profit by segment were as follows:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 | | | | || Semiconductor Products Group | $ | 194,932 | | | $ | 154,082 | | | $ | 550,308 | | | $ | 430,444 | |
| Net sales: | | | | | | | |
| Total | $ | 194,932 | | | $ | 154,082 | | | $ | 550,308 | | |$ | 430,444 | |
| High-Performance Analog Group | $ | 146,601 | | | $ | 125,202 | | | | | |
The following table presents a reconciliation of operating income by segment to consolidated income before taxes and equity in net gains of equity method investments:
| | | | | | | | | | | || | | | | | | | | | | | |
| System Protection Group | 55,548 | | | 45,170 | | | | | |
| Total net sales | $ | 202,149 | | | $ | 170,372 | | | | | |

| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | |October 25, 2020 | | October 31, 2021 | | October 25, 2020 |

| Gross profit: | | | | | | | |
| Semiconductor Products Group | $ | 56,957 | | | $ | 37,668 | | | $ | 148,578 | | | $ | 100,584 | |
| High-Performance Analog Group | $ | 102,061 | | | $ | 83,080 | | | | | |
| System Protection Group | 29,187 | | | 22,741 | | | | | |
| Operating income by segment | 56,957 | | | 37,668 | | | 148,578 | | | 100,584 | |
| Items to reconcile segment operating income to consolidated income before taxes and equity in net gains of equity method investments: | | | | | | | |
| Unallocated costs, including share-based compensation | (995) | | | (960) | | | | | |
| share-based compensation | 17,341 | | | 13,538 | | | 40,697 | | | 36,103 | |
| Intangible amortization | 1,298 | | | 1,798 | | | 3,894 | | | 6,658 | |
| Investment impairments and credit loss reserves | 216 | | | 335 | | | 930 | | | 5,450 | |
| Changes in the fair value of contingent earn-out obligations | - | | | - | | | - | | | (33) | |
| Restructuring and other reserves | - | | | - | | | 16 | | | 502 | |
| Litigation cost, net of recoveries | 434 | | | 558 | | | 1,534 | | |809 | |
| Transaction and integration related | 460 | | | 292 | | | 384 | | | 539 | |
| Total gross profit | $ | 130,253 | | | $ | 104,861 | | | | | |
| Interest expense | 1,233 | | | 1,008 | | | 3,617 | | | 3,819 | |
| Non-operating (income) expense, net | (105) | | | 236 | | | (412) | | | (11) | |
| Income before taxes and equity in net gains of equity method investments | $ | 36,080 | | | $ | 19,903 | | | $ | 97,918 | | | $ | 46,748 | |
Information by Product Line
The Company operates exclusively in the semiconductor industry and primarily within the analog and mixed-signal sector.
The table below provides net sales activity by product line on a comparative basis:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | || |
| | Three Months Ended | | Nine Months Ended |
| (in thousands, except percentages) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |May 1, 2022 | | May 2, 2021 | | | | |
| Signal Integrity | $ | 75,405 | | | 39 | % | | $ | 61,553 | Signal Integrity | $ | 79,302 | | | 40 | % | | $ | 66,695 | | | 39 | % | | | | | | | | |
| Wireless and Sensing | 67,299 | | | 33 | % | | 58,507 | | | 34 | % | | 184,223 | | | 33 | % | | 122,933 | | | 29 | % || | | | | | |
| Protection | 55,548 | | | 27 | % | | 45,170 | | | 27 | % | | 150,898 | | | 27 | % | | 114,384 | | |27 | % || | | | | | |
| Total net sales | $ | 202,149 | | | 100 | % | | $ | 154,082 | | | 100 | % | | $ | 550,308 | | | 100 | % | | $ | 430,444 | | |100 | % |170,372 | | | 100 | % | | | | | | | | |
23
Information by Sales Channel
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| (in thousands, except percentages) | Three Months Ended | | Nine Months Ended |
| | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| | May 1, 2022 | | May 2, 2021 | | | | |
| Distributor | $ | 179,033 | | | 89 | % | | $ | 146,400 | | | 86 | % | | $ | 478,096 | | | 87 | % | | $ | 346,103 | | | 80 | % | | | | | | | |
| Direct | 23,116 | | | 11 | % | | 23,972 | | | 14 | % | | 72,212 | | | 13 | % | | 84,341 | | |20 | % || | | | | | |
| Total net sales | $ | 202,149 | | | 100 | % | | $ | 154,082 | | | 100 | % | | $ | 550,308 | | | 100 | % | |$ | 430,444 | | | 100 | % |170,372 | | | 100 | % | | | | | | | | |
Generally, the Company does not have long-term contracts with its distributors and most distributor agreements can be terminated by either party with short notice. For the first quarter of fiscal year 2023, the Company's largest distributors were based in Asia.
23


Geographic Information
Net sales activity by geographic region was as follows:
| | | | | | | | | | | | | | | | || | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (percentage of total net sales) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |May 1, 2022 | | May 2, 2021 | | | | |
| Asia-Pacific | 76 | % | | 78 | % | | | | |
| North America | 13 | % | | 13 | % | | | | |
| Europe | 10 | % | | 8 | % | | 9 | % | | 8 | % |
| Europe | 11 | % | | 9 | % | | | | |
| | 100 | % | | 100 | % | | | | |
The Company attributes sales to a country based on the ship-to address. The table below summarizes sales activity to countries that represented greater than 10% of total net sales for at least one of the periods presented:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (percentage of total net sales) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |May 1, 2022 | | May 2, 2021 | | | | |
| China (including Hong Kong) | 57 | % | | 60 | % | | | | |
| United States | 12 | % | | 11 | % | | | | |
| | | | | | | | |
| | | | | | | | |
Although a large percentage of the Company's products is shipped into the Asia-Pacific region, a significant number of the products produced by these customers and incorporating the Company's semiconductor products are then sold outside this region.

24


Note 15: Stock Repurchase Program
The Company maintains a stock repurchase program that was initially approved by its Board of Directors in March 2008. The stock repurchase program does not have an expiration date and the Company's Board of Directors has authorized expansion of the program over the years. The following table summarizes activity under the program for the presented periods:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | || | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| | May 1, 2022 | | May 2, 2021 | | | | |
| (in thousands, except number of shares) | Shares | | Amount Paid | | Shares | | Amount Paid | | Shares | | Amount Paid | | Shares | | Amount Paid || | | | | | |
| Shares repurchased under the stock repurchase program | 387,163 | | | $ | 30,000 | | | 439,921 | | | $ | 24,046 | | | 1,387,624 | | | $ | 97,000 | | | 1,527,834 | | |$ | 66,433 | |762,093 | | | $ | 50,000 | | | 360,942 | | | $ | 25,000 | | | | | | | | | |
On March 11, 2021, the Company's Board of Directors approved the expansion of the stock repurchase program by an additional $350.0 million. As of May 1, 2022, the Company had repurchased $589.0 million in shares of its common stock under the program since inception and the remaining authorization under the program was $209.4 million. Under the program, the Company may repurchase its common stock at any time or from time to time, without prior notice, subject to market conditions and other considerations. The Company's repurchases may be made through Rule 10b5-1 and/or Rule 10b-18 or other trading plans, open market purchases, privately negotiated transactions, block purchases or other transactions. The Company intends to fund repurchases under the program from cash on hand and borrowings on its Credit Facility. The Company has no obligation to repurchase any shares under the program and may suspend or discontinue it at any time.
25


Note 16: Derivatives and Hedging Activities
The Company is exposed to certain risks arising from both its business operations and economic conditions and principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company, on a routine basis and in the normal course of business, experiences expenses denominated in Swiss Franc ("CHF"), Canadian Dollar ("CAD") and Great British Pound ("GBP"). Such expenses expose the Company to exchange rate fluctuations between these foreign currencies and the U.S. Dollar ("USD"). The Company occasionally uses derivative financial instruments, in the form of forward contracts, to mitigate a portion of the risk associated with adverse movements in these foreign currency exchange rates during a twelve-month window. Currency forward contracts involve fixing the exchange rate for delivery of a specified amount of foreign currency on a specified date. The Company's accounting treatment for these instruments is based on whether or not the instruments are designated as a hedging instrument. As of May 1, 2022 and January 30, 2022, the Company had no outstanding foreign currency forward contracts.
During the first quarter of fiscal year 2021, the Company entered into an interest rate swap agreement with a three-year term to hedge the variability of interest payments on the first $150.0 million of debt outstanding under the Company's Credit Facility. Interest payments on the first $150.0 million of the Company's debt outstanding under the Credit Facility are now fixed at a rate of 1.9775%, based on the Company's current leverage ratio. The interest rate swap agreement has been designated as a cash flow hedge and unrealized gains or losses, net of income tax, are recorded as a component of "Accumulated Other Comprehensive Income or Loss" in the Balance Sheets. As the various settlements are made on a monthly basis, the realized gain or loss on the settlements are recorded in "Interest expense" in the Statements of Income. The realized loss on the interest rate swap agreement was $0.9 million and $0.7 million for the three and nine months ended October 31, 2021, respectively. The realized loss on the interest rate swap agreement was $0.2 million and $0.3 million for the three and nine months ended October 25, 2020, respectively.interest rate swap agreement resulted in a realized loss of $0.2 million for each of the three months ended May 1, 2022 and May 2, 2021.
The fair values of the Company's derivative assets and liabilities that qualify as cash flow hedges in the Balance Sheets were as follows:
| | | | | | | | | | | | | | | |
| | | Balance as of |
| (in thousands) | | October 31, 2021 | | January 31, 2021 |
| (in thousands) | | May 1, 2022 | | January 30, 2022 |
| Interest rate swap agreement | | $ | 1,983 | | | $ | 62 | |
| Total other current assets | | $ | 1,983 | | | $ | - | |
62 | |
| | | | | |
| Interest rate swap agreement | | $ | - | | | $ | 167 | |
| Total other long-term assets | | $ | - | | | $ | 167 | |
| | | | | |
| | | | | |
| Interest rate swap agreement | | $ | - | || $ | 933 | |
| | | | | |
| | | | | |

| Total other long-term liabilities | | $ | - | || $ | 933 | |
| | | | | |
| | | | | |

| | | | | |
| | | | | |
During the fourth quarter of fiscal year 2021, the Company entered into an economic hedge program that uses total return swap contracts to hedge the market risk associated with the unfunded portion of the Company's deferred compensation liability. The total return swap contracts generally have a duration of one month and are rebalanced and re-hedged at the end of each monthly term. While the total returns swap contracts are treated as economic hedges, the Company has not designated them as hedges for accounting purposes. The total return swap contracts are measured at fair value and recognized in the Balance Sheets in "Accrued Liabilities" if the instruments are in a loss position and in "Other Current Assets" if the instruments are in a gain position. Unrealized gains and losses, as well as realized gains and losses for settlements, on the total return swap contracts are recognized in "Selling, general and administrative expenses" in the Statements of Income. As of May 1, 2022, the notional value of the total return swap contracts was $5.8 million and the fair value resulted in an asset balance of $0.2 million. As of January 31, 2021, a liability of $0.3 million. As of January 30, 2022, the notional value of the total return swap contracts was $7.8 million and the fair value resulted in a liability balance of $0.2 million. The net gain recognized in earnings on the total return swap contracts was $0.4 million and $2.0 million for the three and nine months ended October 31, 2021.respectively.of $0.3 million. The total return swap contracts resulted in a net loss recognized in earnings of $0.4 million for the three months ended May 1, 2022, compared to a net gain recognized in earnings of $1.0 million for the three months ended May 2, 2021.

26


Note 17: Subsequent Event
On May 3, 2022, the Company completed the divestiture of the Disposal Group to Micross Components, Inc. for approximately $30 million in an all-cash transaction. See Note 2, Divestiture, for additional information.

27


ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following "Management's Discussion and Analysis of Financial Condition and Results of Operations" should be read in conjunction with our interim unaudited condensed consolidated financial statements and the accompanying notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q (this "Quarterly Report"), and the "Special Note Regarding Forward-Looking and Cautionary Statements" in this Quarterly Report.
Overview
Semtech Corporation (together with its consolidated subsidiaries, the "Company", "we", "our", or "us") designs, develops, manufactures and markets high-performance analog and mixed signal semiconductors and advanced algorithms. We operate and account for results in one reportable segment through three operating segments, comprised of our product lines:account for results in two reportable segments-the High-Performance Analog Group and the System Protection Group. The High-Performance Analog Group is comprised of our Signal Integrity and Wireless and Sensing product lines, which represent two operating segments. The System Protection Group is comprised of our Protection product line, which represents a separate operating segment.
Signal Integrity. We design, develop, manufacture and market a portfolio of optical data communications and video transport products used in a wide variety of infrastructure and industrial applications. Our comprehensive portfolio of integrated circuits ("ICs") for data centers, enterprise networks, passive optical networks ("PON"), and wireless base station optical transceivers and high-speed interfaces ranges from 100Mbps to 400Gbps and supports key industry standards such as Fibre Channel, Infiniband, Ethernet, PON and synchronous optical networks. Our video products offer advanced solutions for next generation high-definition broadcast applications, as well as highly differentiated video-over-IP technology for professional audio video applications.
Wireless and Sensing. We design, develop, manufacture and market a portfolio of specialized radio frequency products used in a wide variety of industrial, medical and communications applications, and specialized sensing products used in industrial and consumer applications. Our wireless products, which include our LoRa® devices and wireless radio frequency technology, feature industry leading and longest range industrial, scientific and medical radio, enabling a lower total cost of ownership and increased reliability in all environments. These features make these products particularly suitable for machine to machine and Internet-of-Things ("IoT") applications. Our unique sensing technology enables proximity sensing and advanced user interface solutions for our mobile and consumer products. Our wireless and sensing products can be found in a broad range of applications in the industrial, medical, and consumer markets. We also design, develop, and market power product devices that control, alter, regulate, and condition the power within electronic systems focused on the LoRa and IoT infrastructure segment. The highest volume product types within this category are switching voltage regulators, combination switching and linear regulators, smart regulators, isolated switches, and wireless charging.
Protection. We design, develop, manufacture and market high-performance protection devices, which are often referred to as transient voltage suppressors ("TVS"). TVS devices provide protection for electronic systems where voltage spikes (called transients), such as electrostatic discharge, electrical over stress or secondary lightning surge energy, can permanently damage sensitive ICs. Our portfolio of protection solutions include filter and termination devices that are integrated with the TVS device. Our products provide robust protection while preserving signal integrity in high-speed communications, networking and video interfaces. These products also operate at very low voltage. Our protection products can be found in a broad range of applications including smart phones, LCD and organic light-emitting diode TVs and displays, set-top boxes, monitors and displays, tablets, computers, notebooks, base stations, routers, automobile and industrial systems.
Our interim unaudited condensed consolidated balance sheets are referred to herein as the "Balance Sheets" and interim unaudited condensed consolidated statements of income are referred to herein as the "Statements of Income."
Our net sales by product line were as follows:
| | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | | | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | | | May 2, 2021 | | | | |
| Signal Integrity | $ | 75,405 | | | | | $ | 61,553 | | | $ | 215,187 | | | $ | 193,127 | |
| Signal Integrity | $ | 79,302 | | | | | $ | 66,695 | | | | | |
| Wireless and Sensing | 63,123 | | | | | 51,145 | | | 184,223 | | |122,933 | |
| Wireless and Sensing | 67,299 | | | | | 58,507 | | | | | |
| Protection | 56,404 | | | | | 41,384 | | | 150,898 | | | 114,384 | |
| Protection | 55,548 | | | | | 45,170 | | | | | |
| Total | $ | 194,932 | | | | | $ | 154,082 | | | $ | 550,308 | | | $ | 430,444 | |
| Total | $ | 202,149 | | | | | $ | 170,372 | | | | | |
We design, develop and market a wide range of products for commercial applications, the majority of which are sold into the infrastructure, high-end consumer and industrial end markets.
Infrastructure: data centers, PON, base stations, optical networks, servers, carrier networks, switches and routers, cable modems, wireless local area network ("LAN") and other communication infrastructure equipment.
High-End Consumer: smartphones, tablets, wearables, desktops, notebooks, and other handheld products, wireless charging, set-top boxes, digital televisions, monitors and displays, digital video recorders and other consumer equipment.
28


Industrial: IoT applications, analog and digital video broadcast equipment, video-over-IP solutions, automated meter reading, smart grid, wireless charging, military and aerospace, medical, security systems, automotive, industrial and home automation and other industrial equipment.
Our end customers are primarily original equipment manufacturers that produce and sell electronics.
Recent Developments
On May 3, 2022, we completed the divestiture of our high reliability discrete diodes and assemblies business (the "Disposal Group") to Micross Components, Inc. for approximately $30 million in an all-cash transaction. See Note 2, Divestitures, for additional information.
Impact of COVID-19 and Macroeconomic Conditions
The COVID-19 pandemic has significantly affected health and economic conditions throughout the United States ("U.S.") and the rest of the world including Asia, where a significant percentage of our customers, suppliers, third party foundries and subcontractors are located. As a result of the pandemic, certain of our facilities and the third-party foundries and assembly and test contractors to which we outsource our manufacturing functions, have had to periodically reduce or suspend operations. The disruption experienced during such closures has resulted in reduced production of our products, delays for delivery of our products to our customers, and reduced ability to receive supplies, which have had and may continue to have, individually and in the aggregate, an adverse effect on our results.
Currently, customer demand remains strong and supply tight, with many of our suppliers running at or near capacity and our customers competing for limited inventory. While we have increased our inventory levels to prepare for our strong backlog of orders, higher demand and to minimize the impact of potential supply shortages, we cannot provide assurance that we will have sufficient inventory if this high level of demand is sustained over the longer term. In addition, the prices to obtain raw materials and convert them into the necessary inventory have increased in certain cases, and may continue to increase, including due to current inflationary pressures. While we have been largely successful with passing on selective price increases to our customers, we cannot provide assurance that all future potential price increases can be absorbed through increased pricing to our customers.
We believe we have good visibility going into the second quarter of fiscal year 2023; however, it is unknown how much of the increased demand reflects real end market strength. We believe the general supply chain constraints in the industry may be motivating certain customers to increase their orders and inventory levels to protect against supply risk. To the extent that this cautionary purchasing is occurring, we could experience a decrease in future demand as potential excess inventory is worked down.
Factors Affecting Our Performance
Most of our sales to customers are made on the basis of individual customer purchase orders. Many customers include cancellation provisions in their purchase orders. Trends within the industry toward shorter lead-times and "just-in-time" deliveries have reduced our ability to predict future shipments. As a result, we generally rely on orders received and shipped within the same quarter for a significant portion of our sales. As a result of current macro conditions where demand is exceeding supply and we are seeing global shortages, lead times may continue to expand, resulting in fewer orders being shipped and received in the same quarter. Orders received and shipped in the first quarters of fiscal years 2023 and 2022 represented 1% and 18% of net sales, respectively. Sales made directly to customers during the first quarters of fiscal years 2023 and 2022 were 11% and 14% of net sales, respectively. The remaining sales were made through independent distributors. The decline in direct sales is due to customers electing to leverage the value of distribution to better manage their supply chain.
Our business relies on foreign-based entities. Many of our third-party subcontractors and suppliers, including third-party foundries that supply silicon wafers, are located in foreign countries or territories including Taiwan and China. Foreign sales constituted approximately 88% and 89% of our net sales during the first quarters of fiscal years 2023 and 2022, respectively. Approximately 76% and 78% of our sales during the first quarters of fiscal years 2023 and 2022, respectively, were to customers located in the Asia-Pacific region. The remaining foreign sales were primarily to customers in Europe, Canada and Mexico. Doing business in foreign locations also subjects us to export restrictions and trade laws, which may limit our ability to sell to certain customers.
We use several metrics as indicators of future potential growth. The indicators that we believe best correlate to potential future sales growth are design wins and new product releases. There are many factors that may cause a design win or new product release not to result in sales, including a customer's decision not to go to system production, a change in a customer's perspective regarding a product's value or a customer's product failing in the end market. As a result, although a design win or new product introduction is an important step towards generating future sales, it does not inevitably result in us being awarded business or receiving a purchase commitment.
Inflationary factors have not had a significant effect on our performance over the past several years. A significant increase in inflation would affect our future performance if we were unable to pass these higher costs on to our customers.
29


Results of Operations
The following table sets forth, for the periods indicated, our interim unaudited condensed consolidated statements of income expressed as a percentage of net sales.
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| | May 1, 2022 | | May 2, 2021 | | | | |
| Net sales | 100.0 | % | | 100.0 | % | | | | |
| Cost of sales | 36.5 | % | | 39.0 | % | | 37.5 | % | | 38.9 | % |
| Cost of sales | 35.6 | % | | 38.5 | % | | | | |
| Gross profit | 63.5 | % | | 61.0 | % | | 62.5 | % | |61.1 | % |
| Gross profit | 64.4 | % | | 61.5 | % | | | | |
| Operating costs and expenses: | | | | | | | |
| Selling, general and administrative | 24.4 | % | | 27.8 | % | | 23.3 | % | |26.9 | % |21.5 | % | | 22.8 | % | | | | |
| Product development and engineering | 19.2 | % | | 21.6 | % | | | | |
| Intangible amortization | 0.7 | % | | 1.2 | % | | 0.7 | % | |1.5 | % |
| Intangible amortization | 0.5 | % | | 0.8 | % | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Total operating costs and expenses | 44.3 | % | | 47.1 | % | | 44.0 | % | | 48.1 | % |41.2 | % | | 45.1 | % | | | | |
| Operating income | 19.2 | % | | 13.9 | % | | 18.5 | % | |13.0 | % |
| Operating income | 23.3 | % | | 16.4 | % | | | | |
| Interest expense | (0.6) | % | | (0.7) | % | | | | |
| Non-operating income, (expense), net | 0.1 | % | | (0.2) | % | | 0.1 | % | | - | % |
| Non-operating income, net | 0.1 | % | | 0.1 | % | | | | |
| Investment impairments and credit loss reserves | (0.1) | % | | (0.2) | % | | (0.2) | % | |(1.3) | % |- | % | | (0.1) | % | | | | |
| Income before taxes and equity in net gains of equity method investments | 18.5 | % | | 12.9 | % | | 17.8 | % | |10.9 | % |22.8 | % | | 15.6 | % | | | | |
| Provision for income taxes | 1.5 | % | | 1.0 | % | | 1.7 | % | |0.6 | % |
| Provision for income taxes | 4.0 | % | | 1.9 | % | | | | |
| Net income before equity in net gains of equity method investments | 17.0 | % | | 11.9 | % | | 16.1 | % | |10.3 | % |18.8 | % | | 13.7 | % | | | | |
| Equity in net gains of equity method investments | 0.7 | % | | 0.1 | % | | 0.4 | % | |- | % |- | % | | - | % | | | | |
| Net income | 17.7 | % | | 12.0 | % | | 16.5 | % | |10.3 | % |
| Net income | 18.8 | % | | 13.8 | % | | | | |
| Net loss attributable to noncontrolling interest | - | % | | - | % | | | | |
| Net income attributable to common stockholders | 17.7 | % | | 12.0 | % | | 16.5 | % | |10.3 | % |18.8 | % | | 13.8 | % | | | | |
| Percentages may not add precisely due to rounding. | | | | | | | |
Our regional mix of income (loss) from continuing operations before taxes and equity in net gains (losses) of equity method investments was as follows:
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Nine Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 | | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 | | | | |
| Domestic | $ | (5,358) | | | $ | (2,054) | | | $ | (17,466) | | | $ | (19,065) | |
| Domestic | $ | (4,782) | | | $ | (5,484) | | | | | |
| Foreign | 41,438 | | | 21,957 | | | 115,384 | | | 65,813 | |
| Foreign | 50,875 | | | 32,102 | | | | | |
| Total | $ | 36,080 | | | $ | 19,903 | | | $ | 97,918 | | | $ | 46,748 | |
| Total | $ | 46,093 | | | $ | 26,618 | | | | | |
Domestic performance from continuing operations includes higher levels of share-based compensation compared to foreign operations.
Comparison of the Three Months Ended May 1, 2022 and May 2, 2021
Net Sales
The following table summarizes our net sales by major end market:
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| (in thousands, except percentages) | May 1, 2022 | | May 2, 2021 |
| Infrastructure | $ | 76,194 | | | 37 | % | | $ | 61,350 | | | 36 | % |
| High-End Consumer | 47,826 | | | 24 | % | | 53,816 | | | 32 | % |
| Industrial | 78,129 | | | 39 | % | | 55,206 | | | 32 | % |
| Total | $ | 202,149 | | | 100 | % | | $ | 170,372 | | | 100 | % |
Net sales
Net sales for the first quarter of fiscal year 2023 were $202.1 million, an increase of 18.7% compared to $170.4 million for the first quarter of fiscal year 2022. Net sales from our industrial end market increased $22.9 million versus the prior year primarily due to an
29


approximately $19 million increase in LoRa-enabled product sales as we gained traction in the expanding range of IoT applications, an approximately $7 million increase in broadcast product sales and an approximately $5 million increase in broad-based industrial sales, partially offset by declining sales from our legacy Power and High Reliability business. net sales from our high-end consumer end market, increased $15.0 millionled by an increase in pico gateways. We experienced an increase of $14.8 million in net sales from our infrastructure end market, primarily driven by an approximately $6 million increase in our TVS consumer products including smartphones and an approximately $5 million increase in our proximity sensing products. We experienced an increase of $7.9 million in Net sales from our infrastructure end market primarily drivenby an approximately $13 million increase in 10G PON sales, $14 million increase in PON sales. Net sales from our high-end consumer end market decreased $6.0 million primarily driven
30



by an approximately $11 million decrease in our proximity sensing products,
partially offset by an approximately $3 million increase in TVS consumer product sales including wearables, mobile computers and smartphones.
Based on booking trends and our backlog entering the quarter, we estimate net sales for the second quarter of fiscal year 2023 to be between $203.0 million and $213.0 million. The range of guidance reflects continued uncertainty regarding macro-related events and those associated with the COVID-19 pandemic discussed above.
Gross Profit
For The third quarter of fiscal year 2022, gross profit increased to $123.7 million from $94.1 million for the third quarter of fiscal year 2021 as a result of higher sales. Gross margins were 63.5% for the third quarter of fiscal year 2022 compared to 61.0% for the third quarter of fiscal year 2021, reflecting a more favorable product mix. For the fourth quarter of fiscal year 2022, we expect our gross margins to be in the range of 63.1% to 64.1%.
The following table summarizes our net sales by reportable segment:
Operating Costs and Expenses
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | Change |
| (in thousands, except percentages) | October 31, 2021 | | October 25, 2020 | |
| Selling, general and administrative | $ |47,621 | | | 55 | % | | $ | 42,891 | | | 59 | % | | 11 | % |
May 1, 2022 | | May 2, 2021 | | |
| | Net Sales | | % Net Sales | | Net Sales | | % Net Sales | | Change |

| Product development and engineering | 37,346 | | | 43 | % | | 27,890 | | | 38 | High-Performance Analog Group | $ | 146,601 | | | 73 | % | | $ | 125,202 | | | 73 | % | | 17 | % |
| System Protection Group | 55,548 | | | 27 | % | | 45,170 | | | 27 | % | | 23 | % |
| | | | | | | | | | |
| Total operating costs and expenses | $ | 86,265
| Total | $ | 202,149 | | | 100 | % | | $ | 170,372 | | | 100 | % | | 19 | % |
Selling, General and Administrative Expenses
Selling, general and administrative ("SG&A") expenses increased $4.7 million in the third Net sales from our High-Performance Analog Group increased $21.4 million in the first quarter of fiscal year 2023 compared to the first quarter of fiscal year 2022 primarily driven by an approximately $19 million increase in share-based compensation expense driven by remeasurement of the cash-settled awards liability.
Product Development and Engineering Expenses
product development and engineering expenses increased $9.5 million in the third quarter of fiscal year 2022 compared to the third quarter of fiscal year 2021 as a result of an approximately $5 million increase in staffing-related costs, including performance-based compensation,
LoRa-enabled product sales led by an increase in pico gateways and an approximately $14 million increase in operating supplies and contracted research, as well as fluctuations in the timing of development activities. The levels of product development and engineering expenses reported in a fiscal period can be significantly impacted, and therefore experience period over period volatility, by the number of new product tape-outs and by the timing of recoveries from non-recurring engineering services, which are typically recorded as a reduction to product development and engineering expense.PON sales, partially offset by an approximately $11 million decline in proximity sensing products. Net sales from our System Protection Group increased $10.4 million in the first quarter of fiscal year 2023 compared to the first quarter of fiscal year 2022 primarily driven by an approximately $7 million increase in industrial automation and automotive sales and an approximately $3 million increase in TVS consumer product sales, including wearables, mobile computers and smartphones.
Intangible Amortization
Intangible amortization was $1.3 million and $1.8 million for the third quarters of fiscal years 2022 and 2021, respectively. This decrease was primarily due to certain finite-lived intangible assets associated with the acquisition of Gennum Corporation, which became fully amortized during fiscal year 2021.
Interest Expense
Interest expense, including amortization of debt discounts and issuance costs, was $1.2 million and $1.0 million for the third quarters of fiscal years 2022 and 2021, respectively. This increase was primarily due to a $20.0 million draw on the Credit Facility during the third quarter of 2022, which was repaid during the same quarter.
Investment Impairments and Credit Loss Reserves
During the third quarter of fiscal year 2022, investment impairments and credit loss reserves totaled a loss of $0.2 million due to adjustments to our reserve for current expected credit losses. During the third quarter of fiscal year 2021, investment impairments and credit loss reserves totaled a loss of $0.3 million and primarily reflected adjustments to our reserve for current expected credit losses.
30


Provision for Income Taxes
The effective tax rates for the third quarters of fiscal years 2022 and 2021 were provision rates of 8.4% and 7.9%, respectively. in the third quarter of fiscal year 2022, we recorded income tax expense of $3.0 million, compared to $1.6 million in the third quarter of fiscal year 2021. The effective tax rates in the third quarters of fiscal years 2022 and 2021 differ from the statutory federal income tax rate of 21% primarily due to a regional mix of income, excess tax benefits from share-based compensation, withholding taxes on certain foreign earnings and research and development tax credits.
As a global organization, we are subject to audit by taxing authorities in various jurisdictions. To the extent that an audit, or the closure of a statute of limitations, results in adjusting our reserves for uncertain tax positions, our effective tax rate could experience extreme volatility since any adjustment would be recorded as a discrete item in the period of adjustment.
Comparison of the Nine Months Ended October 31, 2021 and October 25, 2020
Gross Profit
The following table summarizes our gross profit and gross margin by reportable segment:
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| (in thousands, except percentages) | October 31, 2021 || October 25, 2020 |May 1, 2022 | | May 2, 2021 |
| | Gross Profit | | Gross Margin | | Gross Profit | | Gross Margin |

| Infrastructure | $ | 195,737 | | | 36 | % | | $ | 185,083 | | | 43 | % |
| High-Performance Analog Group | $ | 102,061 | | | 69.6 | % | | $ | 83,080 | | | 66.4 | % |
| High-End Consumer | 173,337 | | | 31 | % | | 112,507 | | | 26 | % |
| System Protection Group | 29,187 | | | 52.5 | % | | 22,741 | | | 50.3 | % |
| Industrial | 181,234 | | | 33 | % | | 132,854 | | | 31 | % |
| Unallocated costs, including share-based compensation | (995) | | | | | (960) | | | |
| Total | $ | 550,308 | | | 100 | % | | $ | 430,444 | | | 100 | % |
| Total | $ | 130,253 | | | 64.4 | % | | $ | 104,861 | | | 61.5 | % |
Net Sales
Net sales for the first nine months of fiscal year 2022 were $550.3 million an increase of 27.8% compared to $430.4 million for the first nine months of fiscal year 2021. During the first nine months of fiscal year 2022, we experienced strong demand across all three of our end markets compared to the prior year when our net sales were adversely impacted by delays in certain shipments of our products due to COVID-19 related shutdowns, including certain subcontractors in Malaysia. Net sales from our high-end consumer end market increased $60.8 million primarily driven by an approximately $32 million increase in our proximity sensing products and an approximately $23 million increase in our TVS consumer products, including smartphones. Net sales from our industrial end market increased $48.4 million versus the prior year primarily due to an approximately $31 million increase in LoRa-enabled product sales, as we gained traction in the expanding range of IoT applications, and an approximately $12 million increase in broadcast product sales and an approximately $8 million increase in broad-based industrial sales, partially offset by declining sales from our legacy Power and High Reliability business. Net sales from our infrastructure end market increased $10.7 million driven by an approximately $23 million increase in 10G PON sales, and an approximately $6 million increase in broad-based Protection sales, partially offset by an approximately $17 million decline in data center demand.
In the first quarter of fiscal year 2023, gross profit increased to $130.3 million from $104.9 million in the first quarter of fiscal year 2022 as a result of higher sales. This increase included a $19.0 million increase from our High-Performance Analog Group and a $6.4 million increase from our System Protection Group, both of which experienced higher demand and implemented price increases to offset higher manufacturing costs during the first quarter of fiscal year 2023.
Our gross margin was 64.4% in the first quarter of fiscal year 2023, compared to 61.5% in the first quarter of fiscal year 2022. Gross margin in our High-Performance Analog Group was 69.6% in the first quarter of fiscal year 2023, compared to 66.4% in the first quarter of fiscal year 2022, reflecting higher margins in 10G PON and 2.5G PON, as well as a favorable product mix related to LoRa-enabled products. Gross margin in our System Protection Group was 52.5% in the first quarter of fiscal year 2023, compared to 50.3% in the first quarter of fiscal year 2022, reflecting a more favorable industrial automation and automotive product mix.
Gross Profit
For the first nine months of fiscal year 2022, gross profit increased to $344.0 million from $263.1 million for the first nine months of fiscal year 2021 as a result of higher sales. Gross margins were 62.5% For the first nine months of fiscal year 2022 compared to 61.1% for the first nine months of fiscal year 2021, reflecting a more favorable product mix.
The majority of our manufacturing is outsourced, resulting in relatively low fixed manufacturing costs and variable costs that highly correlate with volume. For the second quarter of fiscal year 2023, we expect our gross margins to be in the range of 64.1% to 65.5%.
Despite the capacity constraints within the industry, we expect overall gross profit for the second quarter of fiscal year 2023 to benefit from continued revenue growth. We have increased our inventory levels to try to meet the strong backlog of orders and higher demand, as well as to minimize the impact of potential supply shortages.
31


Operating Costs and Expenses
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | Change |
| (in thousands, except percentages) | October 31, 2021 | | October 25, 2020 | |May 1, 2022 | | May 2, 2021 | |
| Selling, general and administrative | $ | 43,364 | | | 52 | % | | $ | 38,804 | | | 50 | % | | 12 | % |
| Product development and engineering | 38,789 | | | 47 | % | | 36,790 | | | 48 | % | | 5 | % |
| Intangible amortization | 1,048 | | | 1 | % | | 1,298 | | | 2 | % | | (19) | % |
| Changes in the fair value of contingent earn-out obligations | - | | | - | % | | (33) | | | - | % | | 100 | % |
| | | | | | | | | | |
| Total operating costs and expenses | $ | 83,201 | | | 100 | % | | $ | 76,892 | | | 100 | % | | 8 | % |
Selling, General and Administrative Expenses
SG&A expenses increased $12.7 million for the first nine months Selling, general and administrative ("SG&A") expenses increased $4.6 million in the first quarter of fiscal year 2023 compared to the first quarter of fiscal year 2022 primarily as a result of an approximately $11 million increase in staffing-related costs, including performance-based compensation, a $1.8 million increase in performance-based compensation, which is comprised of bonus and share-based compensation, a $0.7 million increase in transaction costs including costs related to the divestiture of our high reliability discrete diodes and assemblies business in May 2022, a $0.5 million increase in depreciation expense and a $0.5 million increase in our environmental reserve.
Product Development and Engineering Expenses
Product development and engineering expenses increased $2.0 million in the first quarter of fiscal year 2023 compared to
31


the first nine months of fiscal year 2021 as a result of an approximately $10
the first quarter of fiscal year 2022 primarily as a result of a $3.1 million increase in staffing-related costs, including performance-based compensation, partially offset by a $1.6 million decrease in operating supplies and contracted research, as well as fluctuations in the timing of development activities. The levels of product development and engineering expenses reported in a fiscal period can be significantly impacted, and therefore experience period over period volatility, by the number of new product tape-outs and by the timing of recoveries from non-recurring engineering services, which are typically recorded as a reduction to product development and engineering expense.
Intangible Amortization
Intangible amortization was $1.0 million and $1.3 million for the first nine months of fiscal years 2022 and 2021, quarters of fiscal years 2023 and 2022, respectively. This decrease was primarily due to certain finite-lived intangible assets associated with the acquisitions of Gennum Corporation, Triune Systems, LLC, and AptoVision Technologies, Inc., acquisition of Trackio International AG, which became fully amortized during fiscal year 2021.
Changes in the Fair Value of Contingent Earn-out Obligations
The change in the fair value of contingent earn-out obligations for the first nine months of fiscal year 2021 reflects the difference between the final earn-out targets achieved for Cycleo SAS in fiscal year 2021 and the forecasted achievement level at the end of fiscal year 2020.
2022.
Interest Expense
Interest expense, including amortization of debt discounts and issuance costs, was $3.6 million and $3.8 million for the first nine months of fiscal years 2022 and 2021, respectively. This decrease was primarily due to lower overall debt levels.remained flat at $1.2 million for the first quarters of fiscal years 2023 and 2022.
Investment Impairments and Credit Loss Reserves
During the first nine months of fiscal year 2022, During the first quarter of fiscal year 2023, investment impairments and credit loss reserves totaled a loss of $0.02 million due to adjustments to our credit loss reserve for our available-for-sale debt securities, and we did not record any impairments on our non-marketable equity investments. During the first quarter of fiscal year 2022, reserve for current expected credit losses. During the first nine months of fiscal year 2021, investment impairments and credit loss reserves totaled a loss of $5.5 million, which reflects $2.7 million of adjustments to our reserve for current expected credit losses, which were, in-part, due to the impact of the COVID-19 pandemic on early-stage development companies. The remaining loss relates to other-than-temporary impairment on three of our equity investments.$0.2 million due to adjustments to our credit loss reserve for our available-for-sale debt securities, and we did not record any impairments on our non-marketable equity investments.
Provision for Income Taxes
The effective tax rates for the first nine months of fiscal years 2022 and 2021 were provision rates of 9.4% and 5.4%, respectively. In the first nine months of fiscal year 2022, quarters of fiscal years 2023 and 2022 were provision rates of 17.5% and 12.0%, respectively. In the first quarter of fiscal year 2023, we recorded income tax expense of $8.1 million, compared to $3.2 million in the first quarter of fiscal year 2022. The increase to our effective tax rate for the first quarter of fiscal year 2023 compared to the first quarter of fiscal year 2022 was mainly due to an increase in global intangible low-taxed income ("GILTI"), driven by the capitalization of research and development ("R&D") costs as mandated by The Tax Cuts and Jobs Act. The effective tax rates in the first quarters of fiscal years 2023 and 2022 differ from the statutory federal income tax rate of 21% primarily due to a regional mix of income, excess tax benefits from share-based compensation, return-to-provision adjustments, withholding taxes.on certain foreign earnings and research and development tax credits.impact of GILTI and R&D tax credits. We have elected to treat GILTI as a period cost and the additional capitalization of R&D costs within GILTI increases our provision for income taxes.
As a global organization, we are subject to audit by taxing authorities in various jurisdictions. To the extent that an audit, or the closure of a statute of limitations, results in adjusting our reserves for uncertain tax positions, our effective tax rate could experience extreme volatility since any adjustment would be recorded as a discrete item in the period of adjustment.

Liquidity and Capital Resources
Our capital requirements depend on a variety of factors including, but not limited to, the rate of increase or decrease in our existing business base; the success, timing and amount of investment required to bring new products to market; sales growth or decline; potential acquisitions; the general economic environment in which we operate; and our ability to generate cash flow from operations, which are more uncertain as a result of the COVID-19 pandemic and its impact on the general economy. Our
32


liquidity needs during this uncertain time will depend on multiple factors, including our ability to continue operations and production of our products, given the global supply constraints, the COVID-19 pandemic's effect on our customers, the availability of sufficient amounts of financing and our operating performance.
We believe that our cash on hand, cash available from future operations and available borrowing capacity under our Credit Facility (as defined below) are sufficient to meet liquidity requirements for at least the next 12 months, including funds needed for our material cash requirements. As of May 1, 2022, we had $275.2 million in cash and cash equivalents and $417.0 million of undrawn capacity on our Credit Facility (as defined below). In addition, on May 3, 2022, we sold our high reliability discrete diodes and assemblies business for approximately $30 million in an all-cash transaction. Over the longer-term, we believe our strong cash-generating business model will continue to provide adequate liquidity to fund our normal operations, which have minimal capital intensity. To the extent that we enter into acquisitions or strategic partnerships, we may be required to raise additional capital through debt issuances or equity offerings. In addition, we expect to refinance our Credit Facility ahead of its maturity in November 2024. While we have not had issues securing favorable financing historically, there is no assurance that we will be able to refinance or secure additional capital at favorable terms, or at all in the future.
A meaningful portion of our capital resources, and the liquidity they represent, are held by our foreign subsidiaries. As of May 1, 2022, our foreign subsidiaries held approximately $256.5 million of cash and cash equivalents, compared to $221.9 million at January 30, 2022.
We expect our future cash uses will be for capital expenditures, repurchases of our common stock, debt repayment and potentially, acquisitions and other investments that support achievement of our business strategies. We expect to fund those cash requirements through our cash from operations and borrowings against our Credit Facility.
32
Credit Facility
On November 7, 2019, we, with certain of our domestic subsidiaries as guarantors, entered into an amended and restated credit agreement (the "Credit Agreement") with the lenders party thereto and HSBC Bank USA, National Association, as administrative agent, swing line lender and letter of credit issuer. The Credit Agreement provides $600.0 million in borrowing capacity of revolving loans under the senior secured first lien credit facility (the "Credit Facility"). The Credit Facility matures on November 7, 2024.
In the first three months of fiscal year 2023, we borrowed $10.0 million against our Credit Facility. and made payments on our Credit Facility that totaled $24.0 million. In the first nine In the first three months of fiscal year 2022, we made payments on our Credit Facility that totaled $12.0 million. As of October 31, 2021, we had $177.0 $4.0 million. As of May 1, 2022, we had $183.0 million of outstanding borrowings against our Credit Facility, which had $417.0 million of undrawn capacity.
The Credit Agreement provides that, subject to certain customary conditions, including obtaining commitments with respect thereto, we may request the establishment of one or more term loan facilities and/or increases to the revolving loans in a principal amount not to exceed (a) $300.0 million, plus (b) an unlimited amount, so long as our consolidated leverage ratio, determined on a pro forma basis, does not exceed 3.00 to 1.00. However, the lenders are not required to provide such increase upon our request.
Interest on loans made under the Credit Facility in U.S. Dollars accrues, at our option, at a rate per annum equal to (1) the Base Rate (as defined below) plus a margin ranging from 0.25% to 1.25% depending upon our consolidated leverage ratio or (2) LIBOR (determined with respect to deposits in U.S. Dollars) for an interest period to be selected by us plus a margin ranging from 1.25% to 2.25% depending upon our consolidated leverage ratio (such margin, the "Applicable Margin"). The "Base Rate" is equal to a fluctuating rate equal to the highest of (a) the prime rate of the Administrative Agent, (b) 0.50% above the federal funds effective rate published by the Federal Reserve Bank of New York and (c) one-month LIBOR (determined with respect to deposits in U.S. Dollars), plus 1.00%. Interest on loans made under the Credit Facility in Alternative Currencies (as defined in the Credit Agreement) accrues at a rate per annum equal to LIBOR (determined with respect to deposits in the applicable Alternative Currency) (other than loans made in Canadian Dollars, for which a special reference rate for Canadian Dollars applies) for an interest period to be selected by us plus the Applicable Margin.
In the first quarter of fiscal year 2021, we entered into an interest rate swap agreement with a three-year term to hedge the variability of interest payments on the first $150.0 million of debt outstanding under our Credit Facility. Based on our current leverage ratio as of May 1, 2022, interest payments on the first $150.0 million of debt outstanding under our Credit Facility are fixed at 1.9775%.
All of our obligations under the Credit Agreement are unconditionally guaranteed by all of our direct and indirect domestic subsidiaries, other than certain excluded subsidiaries, including, but not limited to, any domestic subsidiary the primary assets of which consist of equity or debt of non-U.S. subsidiaries, certain immaterial non-wholly-owned domestic subsidiaries and subsidiaries that are prohibited from providing a guarantee under applicable law or that would require governmental approval to provide such guarantee. The Company and the guarantors have also pledged substantially all of their assets to secure their obligations under the Credit Agreement.
33


No amortization is required with respect to the revolving loans and we may voluntarily prepay borrowings at any time and from time to time, without premium or penalty, other than customary "breakage costs" and fees for LIBOR-based loans.
The Credit Agreement contains customary covenants, including limitations on our ability to, among other things, incur indebtedness, create liens on assets, engage in certain fundamental corporate changes, make investments, repurchase stock, pay dividends or make similar distributions, engage in certain affiliate transactions, or enter into agreements that restrict our ability to create liens, pay dividends or make loan repayments. In addition, we must comply with financial covenants, including maintaining a maximum consolidated leverage ratio, determined as of the last day of each fiscal quarter, of 3.50 to 1.00 or less, provided that, such maximum consolidated leverage ratio may be increased to 4.00 to 1.00 for the four consecutive fiscal quarters ending on or after the date of consummation of a permitted acquisition that constitutes a "Material Acquisition" under the Credit Agreement, subject to the satisfaction of certain conditions. As of May 1, 2022, we were in compliance with the covenants in our Credit Agreement.
The Credit Agreement also contains customary provisions pertaining to events of default. If any event of default occurs, the obligations under the Credit Agreement may be declared due and payable, terminated upon written notice to us and existing letters of credit may be required to be cash collateralized.
On August 11, 2021, we entered into an amendment to the Credit Agreement in order to, among other things, (i) provide for contractual fallback language for LIBOR replacement to reflect the Alternative Reference Rates Committee hardwired approach and (ii) incorporate certain provisions that clarify the rights of the administrative agent to recover from lenders or other secured parties erroneous payments made to such lenders or secured parties.
33


Capital Expenditures and Research and Development
We incur significant expenditures in order to fund the development, design and manufacture of new products. We intend to continue to focus on those areas that have shown potential for viable and profitable market opportunities, which may require additional investment in equipment and the hiring of additional design and application engineers aimed at developing new products. Certain of these expenditures, particularly the addition of design engineers, do not generate significant payback in the short-term. We plan to finance these expenditures with cash generated by our operations and our existing cash balances.
Purchases under our Stock Repurchase Program
We currently have in effect a stock repurchase program that was initially approved by our Board of Directors in March 2008. On March 11, 2021, the Company's Board of Directors approved the expansion of the stock repurchase program by an additional $350.0 million. This program represents one of our principal efforts to return value to our stockholders. We repurchased 762,093 shares of our common stock under this program in the first three months of fiscal year 2023 for $50.0 million. In the first three months of fiscal year 2022, we repurchased 360,942 shares under this program for $25.0 million. As of May 1, 2022, the remaining authorization under this program was $209.4 million. We intend to fund repurchases under the program from cash on hand and borrowings on our Credit Facility. We have no obligation to repurchase any shares under the program and may suspend or discontinue it at any time.
Working Capital
Working capital, defined as total current assets less total current liabilities, fluctuates depending on end-market demand and our effective management of certain items such as receivables, inventory and payables. In times of escalating demand, our working capital requirements may increase as we purchase additional manufacturing materials and increase production. In addition, our working capital may be affected by potential acquisitions and transactions involving our debt instruments. Although investments made to fund working capital will reduce our cash balances, these investments are necessary to support business and operating initiatives. Our working capital, excluding cash and cash equivalents, was $95.8 million and $96.3 million as of October 31, 2021 and January 31, 2021, $109.8 million and $94.3 million as of May 1, 2022 and January 30, 2022, respectively. Our working capital, including cash and cash equivalents, was $372.4 million and $365.2 million as of October 31, 2021 and January 31, 2021, respectively.$385.0 million and $373.9 million as of May 1, 2022 and January 30, 2022, respectively.
Cash Flows
One of our primary goals is to continually improve the cash flows from our existing operating activities. Additionally, we will continue to seek to maintain and improve our existing business performance with capital expenditures and, potentially, acquisitions and other investments that support achievement of our business strategies. Acquisitions may be made for either cash or stock consideration, or a combination of both.
34


In summary, our cash flows for each period were as follows:
| | | | | | | | | | | | |
| | Three Months Ended |
| (in thousands) | October 31, 2021 | | October 25, 2020 |
| (in thousands) | May 1, 2022 | | May 2, 2021 |
| Net cash provided by operating activities | $ | 50,051 | | | $ | 32,585 | |
| Net cash used in investing activities | (10,315) | | | (8,655) | |
| Net cash used in financing activities | (44,153) | | | (34,602) | |
| Net decrease in cash and cash equivalents | $ | (4,417) | | | $ | (10,672) | |
Operating Activities
Net cash provided by operating activities is driven by net income adjusted for non-cash items and fluctuations in operating assets and liabilities.
Operating cash flows for the first three months of fiscal year 2023 compared to the first three months of fiscal year 2022 were favorably impacted by an 18.7% increase in net sales and unfavorably impacted by a $7.1 million incremental increase in inventory spend.a $24.9 million increase in product development and engineering expenses due to higher staffing-related costs, increases in operating supplies and contracted research, and fluctuations in the timing of development activities, and a $12.7 million increase in SG&A expenses due to higher staffing-related costs.
Investing Activities
Net cash used in investing activities was primarily attributable to capital expenditures, premiums paid for corporate-owned life insurance and purchases of investments, offset by proceeds from corporate-owned life insurance.
Capital expenditures were $8.3 million for the first three months of fiscal year 2023, compared to $5.8 million for the first three months of fiscal year 2022. In the first three months of fiscal years 2023 and 2022, we made significant investments to update and expand our production capabilities.
34
In the first three months of fiscal year 2023, we paid $2.0 million for strategic investments, including investments in companies that are enabling the LoRa and LoRaWAN®-based ecosystem, compared to $2.9 million of investments in the first three months of fiscal year 2022.
In the first three months of fiscal year 2022, we paid $6.0 million for premiums on 2023, we received $2.7 million of proceeds from a corporate-owned life insurance death benefit, which included a $1.6 million gain. All $2.7 million of the proceeds were re-invested into our corporate-owned life insurance policy in order to provide substantive coverage for our deferred compensation liability.
Financing Activities
Net cash used in financing activities is primarily attributable to repurchases of outstanding common stock, payments related to employee share-based compensation payroll taxes and payments on our Credit Facility, offset by proceeds on our Credit Facility and proceeds from stock option exercises.
In the first three months of fiscal year 2023, we paid $4.6 million for employee share-based compensation payroll taxes and received $0.4 million in proceeds from the exercise of stock options, compared to payments of $6.2 million for employee share-based compensation payroll taxes and proceeds of $0.6 million from the exercise of stock options in the first three months of fiscal year 2022. We do not directly control the timing of the exercise of stock options. Such exercises are independent decisions made by grantees and are influenced most directly by the stock price and the expiration dates of stock option awards. Such proceeds are difficult to forecast, resulting from several factors that are outside our control. We believe that such proceeds will remain a nominal source of cash in the future.
Critical Accounting Estimates
Our critical accounting estimates are disclosed in "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in Item 7 of our Annual Report on Form 10-K. There have been no significant changes to our policies during the three months ended May 1, 2022. For a discussion of recent accounting pronouncements, see Note 1 to our interim unaudited condensed consolidated financial statements.
Available Information
General information about us can be found on our website at www.semtech.com. The information on our website is for informational purposes only and should not be relied on for investment purposes. The information on our website is not incorporated by reference into this Quarterly Report and should not be considered part of this or any other report filed with the SEC.
We make available free of charge, either by direct access on our website or by a link to the SEC website, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or as soon as
35


reasonably practicable after such reports are electronically filed with, or furnished to, the SEC. Our reports filed with, or furnished to, the SEC are also available directly at the SEC's website at www.sec.gov.
ITEM 3.Quantitative and Qualitative Disclosures About Market Risk
We are subject to a variety of market risks, including commodity risk and the risks related to foreign currency, interest rates and market performance that are discussed in Item 7A of our Annual Report on Form 10-K. Many of the factors that can have an impact on our market risk are external to us, and so we are unable to fully predict them.
We considered the historical trends in foreign currency exchange rates and determined that it is reasonably possible that adverse changes in foreign exchange rates of 10% for all currencies could be experienced in the near-term. These reasonably possible adverse changes were applied to our total monetary assets and liabilities denominated in currencies other than our functional currency as of the end of our first quarter of fiscal year 2023. The adverse impact these changes would have had (after taking into account balance sheet hedges only) would not have had a material impact on our income before taxes.
We are subject to interest rate risk in connection with the portion of the outstanding debt under our Credit Facility that bears interest at a variable rate as of May 1, 2022. During fiscal year 2021, we entered into an interest rate swap agreement with a three-year term to hedge the variability of interest payments on the first $150.0 million of debt outstanding under our Credit Facility. Based on our current leverage ratio as of May 1, 2022, interest payments on the first $150.0 million of our debt outstanding under our Credit Facility are fixed at 1.9775%. See above under "Liquidity and Capital Resources - Credit Facility" for the interest rates applicable to U.S. and Alternative Currencies borrowings under our Credit Facility in excess of $150.0 million. Based upon the amount of our outstanding indebtedness as of May 1, 2022, a one percentage point increase in LIBOR would not have a material impact on our interest expense as only $33.0 million of our outstanding debt balance remains subject to a floating rate.
The Chief Executive of the U.K. Financial Conduct Authority (the "FCA"), which regulates LIBOR, has announced that the FCA will no longer persuade or compel banks to submit rates for the calculation of LIBOR after 2021. For U.S. dollar LIBOR,
35


publication of the one-week and two-month LIBOR settings ceased on December 31, 2021, and publication of the overnight and 12-month LIBOR settings will cease after June 30, 2023. Immediately after June 30, 2023, the one-month, three-month and six-month U.S. dollar LIBOR settings will no longer be representative. Given these changes, the LIBOR administrator has advised that no new contracts using U.S. dollar LIBOR should be entered into after December 31, 2021. It is also possible that U.S. LIBOR will be discontinued or modified prior to June 30, 2023.
Our Credit Facility provides that, if it is publicly announced that the administrator of LIBOR has ceased or will cease to provide LIBOR, if it is publicly announced by the applicable regulatory supervisor that LIBOR is no longer representative, or if either the administrative agent or lenders holding 50% of the aggregate principal amount of our revolving commitments and term loans elect, we and the administrative agent may amend our Credit Agreement to replace LIBOR with an alternate benchmark rate. This alternative benchmark rate may include a forward-looking term rate that is based on the secured overnight financing rate, also known as SOFR, published by the Federal Reserve Bank of New York.
Interest rates also affect our return on excess cash and investments. As of May 1, 2022, we had $275.2 million of cash and cash equivalents. A majority of our cash and cash equivalents generate interest income based on prevailing interest rates. Interest income, net of reserves, generated by our investments and cash and cash equivalents was not material in the first quarter of fiscal year 2023. A significant change in interest rates would impact the amount of interest income generated from our cash and investments. It would also impact the market value of our investments.
Our investments are primarily subject to credit risk. Our investment guidelines prescribe credit quality, permissible investments, diversification, and duration restrictions. These restrictions are intended to limit risk by restricting our investments to high quality debt instruments with relatively short-term durations. Our investment strategy limits investment of new funds and maturing securities to U.S. Treasury, Federal agency securities, high quality money market funds and time deposits with our principal commercial banks. Outside of these investment guidelines, we also invest in a limited amount of debt securities in privately held companies that we view as strategic to our business. For example, many of these investments are in companies that are enabling the LoRa and LoRaWAN®-based ecosystem.We evaluate the credit risk of these investments on a quarterly basis and increased our current credit loss and reserves by $0.9 million during the nine months ended October 31, 2021, related to the credit risk on our debt securities investments, resulting in a current expected credit loss reserve balance on our available-for-sale and held-to-maturity debt securities of $4.3 million as of October 31, 2021.
36


ITEM 4.Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), which are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), as appropriate to allow timely decisions regarding required disclosure. Our management, with the participation of our CEO and CFO, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. Based on that evaluation, our CEO and CFO concluded that, our disclosure controls and procedures were effective as of May 1, 2022.
Changes in Internal Controls
As of May 1, 2022, there were no changes to our internal control over financial reporting that occurred during the fiscal quarter then ended that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
37


PART II - OTHER INFORMATION

ITEM 1.Legal Proceedings
Information about our material legal proceedings is set forth in Note 12 to the interim unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report and incorporated by reference herein.
ITEM 1A.Risk Factors
Please carefully consider and evaluate all of the information in this Quarterly Report and the risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended January 30, 2022. If any of these risks actually occur, our business could be materially harmed. If our business is harmed, the trading price of our common stock could decline.
The risk factors associated with our business have not materially changed as compared to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021, other than as set forth below.
Risks Relating to Macroeconomic and Industry Conditions
The COVID-19 pandemic is adversely affecting, and is expected to continue to adversely affect, our operations, and those of our customers, distributors, suppliers, third-party foundries and subcontractors thereby adversely affecting our business, financial condition and results of operations.
The COVID-19 pandemic negatively impacted our financial results by decreasing sales, driven by supply chain interruptions, which primarily impacted the first half of fiscal year 2021. For example, in the first quarter of fiscal year 2021, some shipments of our products were delayed due to COVID-19 related shutdowns of our plant in Reynosa, Mexico, as well as some subcontractors in Malaysia. In addition, some of our suppliers have experienced temporary reductions or closures, impacting our ability and the ability of our subcontractors to receive certain raw materials, including silicon wafers, which are essential to the manufacturing of our products. In some cases, the disruption has resulted in reduced production of our products and delays for delivery of our products to our customers. We believe the general supply chain constraints in the industry may be motivating certain customers to increase their inventory to protect against the supply risk. To the extent that this is occurring, we could experience a decrease in future demand as potential excess inventory in the supply chain is worked down.
While we cannot predict the ultimate impact of the COVID-19 virus on our business at this time, the pandemic and related efforts to mitigate the pandemic could impact our business in a number of ways, including but not limited to decreasing demand and pricing for our products as a result of the economic impact of the pandemic; disrupting our manufacturing processes, as has already occurred with the temporary reductions or closures of our facilities, third-party foundries and contractors, and the delay of supplies being received; disrupting freight infrastructure, thereby delaying shipment from vendors to assembly and test sites and shipments of our final product to customers; disrupting the manufacturing process of our customers that use our components in their products, impacting demand for our products; adversely impacting the business of our suppliers, which could result in, among other things, price increases and delays for delivery of raw materials and components needed for the production of our products; impacting our ability to maintain our workforce during this uncertain time; increasing employee absenteeism due to infection or the fear of infection; possible lawsuits or additional regulatory actions due to COVID-19 spread in the workplace and potential increases in costs to implement health safety measures; suffering from reputational risk if we experience COVID-19 spread in our workplace; and adversely impacting the productivity of management and our employees that are working remotely. Additionally, there is an increased risk that we may experience cybersecurity-related events such as COVID-19 themed phishing attacks and other security challenges as a result of most of our employees and our service providers working remotely from non-corporate managed networks during the ongoing COVID-19 pandemic and potentially continuing working remotely even after the COVID-19 pandemic has subsided.
Further, any COVID-19 vaccine or testing mandate imposed on our employees, whether due to regulations enacted by the U.S. Department of Labor's Occupational Safety and Health Administration or otherwise, could result in increased costs, labor disruptions or employee attrition. If we lose employees, it may be difficult in the current competitive labor market to find replacement employees, which could have an adverse effect on future revenues and costs.
In addition, the pandemic has impacted the operations of our distributors and direct customers. Because a significant majority of our net sales is through authorized distributors, the financial health of our distributors is critical to our success. Some of our distributors are small organizations with limited working capital. Our distributors have experienced disruptions to their operations during the pandemic, including temporary reductions or closures during which they have diminished ability or are unable to sell our products. If our distributors suffer material economic harm during the pandemic, the distributors may no longer be able to continue in business or may continue in a reduced capacity. Our direct customers have also experienced, and may continue to or again experience, reductions or closures of their manufacturing facilities or an inability to obtain other components, either of which could negatively impact demand for our products that are incorporated into our customers' devices and solutions.
37


The ultimate magnitude of the COVID-19 pandemic, including the extent of its impact on our financial condition and results of operations, which could be material, will depend on all of the factors noted above, including other factors that we may not be able to foresee at this time.
30, 2022.
ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds
Recent Sales of Unregistered Securities
None.
Issuer Purchase of Equity Securities
This table provides information with respect to purchases by us of shares of our common stock during the first quarter of fiscal year 2023.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Month/Year | | Total Number of | | Average Price Paid | | Total Number of | | Approximate Dollar |
| | | Shares Purchased | | per Share | | Shares Purchased | | Value of Shares That May Yet Be Purchased Under |
| | | | | | | as Part of Publicly Announced Program | | The Program (1) |
| February 2022 (01/31/22-02/27/22) | | - | | | $ | - | | | - | | | $ | 259.4 | million |
| September 2021 (08/30/21-09/26/21) | | 160,925 | | | 77.11 | | | 160,925 | | | $ | 309.8 | million |
| March 2022 (02/28/22-03/27/22) | | 126,060 | | | 70.25 | | | 126,060 | | | $ | 250.5 | million |
| October 2021 (09/27/21-10/31/21) | | 226,238 | | | 77.75 | | | 226,238 | | | $ | 292.2 | million |
| April 2022 (03/28/22-05/01/22) | | 636,033 | | | 64.69 | | | 636,033 | | | $ | 209.4 | million |
| Total activity | | 387,163 | | | $ | 77.49 | | | 387,163 | | | |
| Total activity | | 762,093 | | | $ | 65.61 | | | 762,093 | | | |
(1)The Company maintains an active stock repurchase program that was initially approved by our Board of Directors in March 2008. The stock repurchase program does not have an expiration date and our Board of Directors has authorized expansion of the program over the years. As of May 1, 2022, we have repurchased $589.0 million in shares of our common stock under the program since inception and the current remaining authorization under our stock repurchase program is $209.4 million. Under our stock repurchase program, we may repurchase our common stock at any time or from time to time, without prior notice, subject to market conditions and other considerations. Our repurchases may be made through Rule 10b5-1 and/or Rule10b-18 or other trading plans, open market purchases, privately negotiated transactions, block purchases or other transactions. We intend to fund repurchases under the program from cash on hand and borrowings on our Credit Facility. We have no obligation to repurchase any shares under the stock repurchase program and may suspend or discontinue it at any time.
ITEM 3.Defaults Upon Senior Securities
None.
ITEM 4.Mine Safety Disclosures
Not applicable.
ITEM 5.Other Information
None.

38


ITEM 6.Exhibits
Documents that are not physically filed with this report are incorporated herein by reference to the location indicated.
| | | | | | | | | | | | | | | |
| Exhibit No. | | Description | | Location |
| | | | | |
| 3.1 | | Restated Certificate of Incorporation of Semtech Corporation | | Exhibit 3.1 to our Quarterly Report on Form 10-Q for the quarter ended October 26, 2003 |
| | | | | |
| 3.2 | | Bylaws of Semtech Corporation | | Exhibit 3.2 to our Annual Report on Form 10-K for the fiscal year ended January 27, 2008 |
| | | | | |
| 10.1 | | First Amendment to Second Amended and Restated Credit Agreement, dated as of August 11, 2021, among Semtech Corporation, as borrower, the guarantors party thereto, the lenders party thereto and HSBC Bank USA, National Association, as administrative agent for the secured parties, swing line lender and L/C issuer. | | Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended August 1, 2021 |
| | | | | |
| 31.1 | | Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended | | Filed herewith |
| | | | | |
| 31.2 | | Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended | | Filed herewith |
| | | | | |
| 32.1 | | Certification of the Chief Executive Officer Pursuant to 18 U.S.C. §1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Exhibit 32.1 is being furnished and shall not be deemed "filed") | | Furnished herewith |
| | | | | |
| 32.2 | | Certification of the Chief Financial Officer Pursuant 18 U.S.C. §1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Exhibit 32.2 is being furnished and shall not be deemed "filed") | | Furnished herewith |
| | | | | |
| 101 | | The following financial statements from the Company's Quarterly Report on Form 10-Q for the quarter ended May 1, 2022, formatted in Inline XBRL: (i) Consolidated Statements of Income, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets (iv) Consolidated Statements of Stockholders' Equity, (v) Consolidated Statements of Cash Flow and (v) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags. | | |
| | | | | |
| 104 | | The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended May 1, 2022, formatted in Inline XBRL (included as Exhibit 101). | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |


39


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| | | | | | | | | | | | |
| | | | |
| | | | SEMTECH CORPORATION |
| | | | Registrant |
| | | | |
| Date: | June 1, 2022 | | /s/ Mohan R. Maheswaran |
| | | | Mohan R. Maheswaran |
| | | | President and Chief Executive Officer |
| | | | (Principal Executive Officer; Duly Authorized Officer) |
| | | | |
| Date: | June 1, 2022 | | /s/ Emeka N. Chukwu |
| | | | Emeka N. Chukwu |
| | | | Executive Vice President and |
| | | | Chief Financial Officer |
| | | | (Principal Financial Officer) |
40

Exhibit 31.1

CERTIFICATION
I, Mohan R. Maheswaran, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Semtech Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: June 1, 2022

| | | |
| /s/ Mohan R. Maheswaran |
| Mohan R. Maheswaran |
| President and Chief Executive Officer |


Exhibit 31.2

CERTIFICATION
I, Emeka N. Chukwu, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Semtech Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: June 1, 2022

| | | |
| /s/ Emeka N. Chukwu |
| Emeka N. Chukwu |
| Executive Vice President and Chief Financial Officer |


Exhibit 32.1
CERTIFICATION PURSUANT TO
18 USC 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Semtech Corporation (the "Company") for the period ended May 1, 2022 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mohan R. Maheswaran, Chief Executive Officer of the Company, hereby certify pursuant to 18 USC §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 1, 2022


| | | |
| /s/ Mohan R. Maheswaran |
| Mohan R. Maheswaran |
| President and Chief Executive Officer |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002, has been provided to Semtech Corporation and will be retained by Semtech Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
The information contained in this Exhibit 32.1 is being furnished and shall not be deemed "filed" for the purposes of section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Exhibit 32.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference to this Exhibit 32.1 in such filing.


Exhibit 32.2
CERTIFICATION PURSUANT TO
18 USC 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Semtech Corporation (the "Company") for the period ended May 1, 2022 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Emeka N. Chukwu, Chief Financial Officer of the Company, hereby certify pursuant to 18 USC §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 1, 2022


| | | |
| /s/ Emeka N. Chukwu |
| Emeka N. Chukwu |
| Executive Vice President and Chief Financial Officer |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002, has been provided to Semtech Corporation and will be retained by Semtech Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
The information contained in this Exhibit 32.2 is being furnished and shall not be deemed "filed" for the purposes of section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Exhibit 32.2 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference to this Exhibit 32.2 in such filing.